ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000112.1|Neocarzinostatin_1 # 1 # 798 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.738	BGC0000112.1|Neocarzinostatin_1 	1	798	+	Loose	500	28.1054	ErmH	31.91	3002823	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GTGCCCGTCGACCTGGCATCCGACTCCGTCGGCCGACTGTCCGAGAGTTTGGCCGCGGCAGCGCCCGACGCCCTCGTCAACTGCGTCGGAGCGACTGGTGGCGACCCGGTGAGGCTCGCGGAAGTCAACGCCCGCGGCCCGGCCGTGCTCTGTGCGCCGCTGCTCCGAGCCCGTCCCACCGCCCGCCTGGTGCATCTGGGGTCAGCCGCCGAGTACGGCCCCCAAACGGACCGGGTCCCCGCGTCGGAGTCGGCGGCCACCCGTCCGGTGACCGTCTACGGTGCCACGAAACTGGCCGGCACGGTGACGGTGTCCGACTCGGGGCTGGACGCACTGGTCCTGCGAGTCGGCAACCCGGTGGGGGCCGGCGCACCGGCCTCGGGACTGCCCGGCCGAGTCTGCGCTCTTCTGCGGAAGACGGGCACCGGCCCCGACGTGGTGCTGCGCCTGGGCGACTTGTCGGCGTACCGGGACTTCGTCGACGTGCGCGACGTGGCCCGGGCAGTGGAGCGGGCGGTGACCGCCCCCGGACCACTGCCGCCCGTGCTCAACGTAGGCGGCGGGGAGGCCGTCTTGGGGCGCGATCTGGTGCATCGGCTGGCGGACACTGCCGGCTTCCGCGGGCGCATCGAGGAACAGGGCACCGGTTCCGCCCGGTCGGAGCACATCTCCTGGCAGTGCTCGGACATCTCCGCCGCCGCCGAGGTCCTCGGCTGGCAGCCCACGTACTCGCTCGCCCGTTCGCTGGAGGCGCTGTGGTCGGCCGGAGCGCACCTGGAAGGCGACCGTCCGGCGTGA	VPVDLASDSVGRLSESLAAAAPDALVNCVGATGGDPVRLAEVNARGPAVLCAPLLRARPTARLVHLGSAAEYGPQTDRVPASESAATRPVTVYGATKLAGTVTVSDSGLDALVLRVGNPVGAGAPASGLPGRVCALLRKTGTGPDVVLRLGDLSAYRDFVDVRDVARAVERAVTAPGPLPPVLNVGGGEAVLGRDLVHRLADTAGFRGRIEEQGTGSARSEHISWQCSDISAAAEVLGWQPTYSLARSLEALWSAGAHLEGDRPA	MAALLKRILRRRMAEKRSGRGRMAAARTTGAQSRKTAQRSGRSEADRRRRVHGQNFLVDRETVQRFVRFADPDPGEVVLEVGAGNGAITRELARLCRRVVAYEIDRHFADRLREATAEDPRIEVVAGDFLKTSQPKVPFSVVGNIPFGNTADIVDWCLNARRLRTTTLVTQLEYARKRTGGYRRWSRLTVATWPEVEWRMGERISRRWFRPVPAVDSAVLRLERRPVPLIPPGLMHDFRDLVETGFTGKGGSLDASLRRRFPARRVAAGFRRARLEQGVVVAYVTPGQWITLFEELHGR	88.63	gnl|BL_ORD_ID|1100|hsp_num:0	1193			411	693	erythromycin; lincomycin; pristinamycin IC; oleandomycin; carbomycin
BGC0000112.1|Neocarzinostatin_2 # 1074 # 2654 # 1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.685	BGC0000112.1|Neocarzinostatin_2 	1074	2654	+	Loose	800	27.7202	APH(4)-Ib	32.86	3002656	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(4)	GTGACCACAGCTGAGACCGCCACTGGTCCGGTCGTCGTCGACGGCGAGAGCCTCAGCGTCGATGCCCTGCGTCAGGTCGCGGAGTCAGGGACCCCCGTGAAGGTCCACACCGAAGCGATGGAGAAGGTACTCAGGAGCCGTGCCTCGCTGGAGAGCATGATCATTCGCGGCGAGCCCGTACCTGGTGCCGTCGGCGGTGACGGCCGTGAGAGCCCGCCAGGCATCGATGTGGCGCGGGAGTCCGAACGGCAGACGAACCTGGTGCGCAGCCACAGCGTCGGCGTCGGGCCCCTGTACGCCGAGGACGAGGCACGAGCCATGGTGACGGCGCGTCTGAACTCTCTGGCCAAAGGGCACTCGGCCGTGCGACCGGACATACTCGACCGCATGGTGCTCTATCTGAACGAGGGGATAATCCCGGCCGTGCCCGAGATCGGATCATCTGGTCCGGTTGATCTCGTTCCCCTCGCCCATGTGGCAAGCACCCTGATCGGGGAAGGGCATGTTCTGCACGACGGCAGGCGCCAGGAGACCCGCAGGGTCCTGGGCGCGATGGGAGTCGCACCGCTCCGGCTCGGTGTCAAGGAGGGCACTGCGCTGATCAATGGCACGTCGGGCACGGTCGGCCTGGGAGCGCTCGTGGTGGCACGAGCCCTTGACCAGGTGCGCCAGGCAGAGATCGCCTCGGCCTTCTTCGACGACGCGGTGCGAGGTTCCGACAGCCCGTTCCTGGCCGAAGGACATGACACGGCCCGTCCACATCGGGGGCAGATCGACTCGGCCGCCAACTTGCGTGATCTGCTGGCGGACAGCCGGGGGCGGCGGGAAACGGAGCACGGGGGTGCCGTGCTCGGGTTCCCGGGGCCGCAGGTACCCGGCTTCTACACGGCACGCACGGTGCCGCAGGTGCTCGGCGCGGCCCGGGACGCCCTCCGGCACGCTACGGAGGAGCTGGAGGCAGAACTCAACTCCGCGAACGACGAACCTCTCTTCTTACCGGACGGAAAAGTCCTCCACGGCGGAACCGCCCAGGGGCGGGCCGTGGCGCTCGCCCTGGAGTTTGTCGCCATCGCGCTCAGCCACGTCGGCGAGCTGGCCGAACGGCAGATCGACCGCATGCTCACCCGGCGTCCGGCCTCCGGCGTTGCGCGGTACCTCGTGGCGGCGGATCCGACGCTGCACCATGGTTTCGCGGGCGTCGGCCACACAGCGCGGGCCCTCACGGCGGAGAACCTGGCGGTCGGCACTGCCGCTGCTCAGGTCGTTACCGCCTTCGGCGACGACCGGCCAACGGCCGGCACCGGGCTCCTGGCGGCCCGCAACGCACGACGCGTGCTGCAGAACAATGATCGGATCATTGCCATTGGCCTCATCGTCGCAGCTCAGGCCGCCGACCTCGCTCGGAGATTCGATGATCTGAGCCGGGCGAACATGGCCACGTACGACATGGTGCGTTCCCTGGTCCCGTCCCTCGGCGTCGACCGTTCGATGGCGCAGGACGTCGAGTTGATCGCCACTGCCCTGTCCCGGGCAGAGTTCCTCCATCTGCTCCTGCGGCAGGAGGGGATCGTTCTGCGCTGA	MTTAETATGPVVVDGESLSVDALRQVAESGTPVKVHTEAMEKVLRSRASLESMIIRGEPVPGAVGGDGRESPPGIDVARESERQTNLVRSHSVGVGPLYAEDEARAMVTARLNSLAKGHSAVRPDILDRMVLYLNEGIIPAVPEIGSSGPVDLVPLAHVASTLIGEGHVLHDGRRQETRRVLGAMGVAPLRLGVKEGTALINGTSGTVGLGALVVARALDQVRQAEIASAFFDDAVRGSDSPFLAEGHDTARPHRGQIDSAANLRDLLADSRGRRETEHGGAVLGFPGPQVPGFYTARTVPQVLGAARDALRHATEELEAELNSANDEPLFLPDGKVLHGGTAQGRAVALALEFVAIALSHVGELAERQIDRMLTRRPASGVARYLVAADPTLHHGFAGVGHTARALTAENLAVGTAAAQVVTAFGDDRPTAGTGLLAARNARRVLQNNDRIIAIGLIVAAQAADLARRFDDLSRANMATYDMVRSLVPSLGVDRSMAQDVELIATALSRAEFLHLLLRQEGIVLR	MLQTSKKKSGHDESWANADAHKWRGERKRDNRKIVLSGTTKLLFVAEEQFQLIPPPSYCVSLVPKLPSNVTQPLFEYCFAPRILFFYALKKMTQHTKLCKLSSLIWREMWAISSRLQWQCVCAARRITMRNGGWKFIEMLSCWSDMVHKHESVLISTLPSFINFLVGPFRSAGAEPGGMHRRVDPPRPLSPALIEAFDGVMQLSGAPSRGVTPTPRGPDALGRITDSRGGSEAGYRFNMCNRAVPSAALPIGEVLDIGEFSGKRTYLAAVHRAREQDLPETELPAVLQPCTGMAHAIAAADLSHTSGFAPFGPQGMGQETPWRDKRDCYFDPQVYYWLSQMGDTLRASVAQGFEKRMLWAEDCPEARHLRIHVKGSNAALPEPGPKTWAGDGSQAVWAGRLRPTQDSRYVVASIFPWRPW	125.24	gnl|BL_ORD_ID|1547|hsp_num:0	1681			744	936	hygromycin B
BGC0000112.1|Neocarzinostatin_3 # 2853 # 3407 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.746	BGC0000112.1|Neocarzinostatin_3 	2853	3407	+	Loose	275	25.7942	AAC(6')-Iad	29.23	3002572	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGAGCTACATCCCCCTGTTGGATTCCACCCCGAGGAATGCTCTGATCAGCGGGTGCCGCAGAACGTCCGTGGGGTGCCATGCCGAGGGGCCGACGAGCGCACTGGCCACCGTTGCCCCCGCGTACACGGCCGATTCCGCGCGCCTGGCCGCAGCCGCGCTGATGCGTCTGTTCATGGACCAAGGTGTTCCCGGCTTCGGTTTCGCCGACCCGCAGGGCCTGGAGGACGGGCTGGGGACGGGAGAAGGGGCGTCGACTGCCCCGGTCGGTGCCGCTGACGGCCGGGGCGCGGCAGGGCCCGGGAGCCGTGCTGCGGGTGCGCCCACGACCGCGGCGTCCGGCCCCCCGGTGCCCAGCCGCGCGGCGACGGCGGAAGCCGAGTCCCCGTTGGCCCTGCGCCGCCGTCGCCGCCGTGTCCGGTTCGCGAGGAGAGGCATCGTCACCGGCCGGACGCAGGCCGAGGAGGGCCGCCACGGCCGACACGTGAACGCTGCGCCCCCGACGACGGCACCGGGCGACCCGGCCGTGGTACACGGCGGGGAGGAGGAACGTTGA	MSYIPLLDSTPRNALISGCRRTSVGCHAEGPTSALATVAPAYTADSARLAAAALMRLFMDQGVPGFGFADPQGLEDGLGTGEGASTAPVGAADGRGAAGPGSRAAGAPTTAASGPPVPSRAATAEAESPLALRRRRRRVRFARRGIVTGRTQAEEGRHGRHVNAAPPTTAPGDPAVVHGGEEER	MIRKATVQDPPLLARLAMNVWKESSLKELVAEFEQMTKSNDAVAFILFIEDQAVGFAQCQLRHDYVEGTNTSPVGYLEGIFVEKEFRHRGYASELLLKCEDWVKTKGCLQFASDCELDNIDSLAFHLKVGFTEANRMICFTKQL	127.78	gnl|BL_ORD_ID|1763|hsp_num:0	1911			60	237	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0000112.1|Neocarzinostatin_5 # 4515 # 5576 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=15bp;gc_cont=0.681	BGC0000112.1|Neocarzinostatin_5 	4515	5576	+	Loose	556	30.0314	erm(32)	48.28	3004592	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGTTCTCGGCAATCACGGATAAGGAGCGGGCTTGTGCCCGCCGGGCGGAGAAGGGATCGGGTGTGGGAAAAAGGGCTGCACACATCGGATTGAGGGCGCTGGCCGATCTGGCGACTCCCATGGCGGTCCGCGTGGCGGCCACGCTGCGGGTCGCCGATCACATAGCGGCCGGACACCGCACCGCCGCGGAGATCGCCTCCGCGGCCGGAGCACATGCGGATTCCCTGGACAGGTTGCTGCGCCACCTGGTCGCCGTCGGTCTGTTCACCAGGGACGGCCAGGGCGTCTACGGTCTGACAGAGTTTGGGGAGCAGCTGCGCGACGACCACGCTGCCGGAAAACGCAAGTGGCTGGACATGAACAGTGCCGTGGGGCGGGGCGACCTCGGTTTCGTCGAGTTGGCCCACAGCATTCGCACGGGGCAGCCCGCGTACCCGGTGCGCTACGGAACGTCCTTCTGGGAGGACCTTGGCTCCGACCCCGTTCTCTCGGCGTCCTTCGACACCCTGATGAGCCATCACCTGGAGCTGGACTACACCGGCATCGCAGCCAAGTACGACTGGGCTGCCCTCGGGCATGTCGTCGACGTGGGCGGCGGCAGCGGCGGATTGCTCAGCGCACTGCTGACAGCCCACGAGGACCTGTCGGGAACCGTCCTCGACCTGCAAGGGCCGGCATCGGCCGCGCACCGCAGGTTTCTGGACACCGGGTTGTCCGGACGGGCACAGGTGGTGGTGGGCAGCTTCTTCGACCCATTACCGGCCGGCGCGGGCGGCTACGTGCTGTCTGCCGTCCTGCACGACTGGGACGACCTGTCCGCCGTGGCGATCCTGAGGCGGTGCGCGGAGGCGGCCGGCAGCGGAGGCGTCGTGCTCGTCATCGAAGCGGTGGCCGGCGACGAGCACGCCGGCACCGGCATGGATCTGCGCATGCTCACCTACTTCGGAGGCAAGGAACGCAGCCTTGCCGAACTAGGCGAACTCGCCGCACAGGCCGGCCTCGCCGTACGCGCGGCCCACCCGATCAGCTACGTCTCGATAGTCGAAATGACCGCCCTCTGA	MFSAITDKERACARRAEKGSGVGKRAAHIGLRALADLATPMAVRVAATLRVADHIAAGHRTAAEIASAAGAHADSLDRLLRHLVAVGLFTRDGQGVYGLTEFGEQLRDDHAAGKRKWLDMNSAVGRGDLGFVELAHSIRTGQPAYPVRYGTSFWEDLGSDPVLSASFDTLMSHHLELDYTGIAAKYDWAALGHVVDVGGGSGGLLSALLTAHEDLSGTVLDLQGPASAAHRRFLDTGLSGRAQVVVGSFFDPLPAGAGGYVLSAVLHDWDDLSAVAILRRCAEAAGSGGVVLVIEAVAGDEHAGTGMDLRMLTYFGGKERSLAELGELAAQAGLAVRAAHPISYVSIVEMTAL	MRKNVVRYLRCPHCAAPLRSSDRTLRCENGHTFDVARQGYVNLLRRPTKLAADTTDMVAARAALLDSGHYAPLTERLAGTARRAAGAGAPDCVVDIGGGTGHHLARVLEEFEDAEGLLLDMSKPAVRRAARAHPRASSAVADVWDTLPLRDGAAAMALNVFAPRNPPEIRRILRPGGTLLVVTPQQDHLAELVDALGLLRVRDHKEGRLAEQLAPHFEAVGQERLRTTLRLDHDALGRVVAMGPSSWHQDPDELARRIAELPGIHEVTLSVTFTVCRPLP	126.07	gnl|BL_ORD_ID|2699|hsp_num:0	3294			276	363	narbomycin; methymycin; pikromycin
BGC0000112.1|Neocarzinostatin_6 # 5702 # 6124 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.669	BGC0000112.1|Neocarzinostatin_6 	5702	6124	+	Loose	1800	25.0238	mexY	61.11	3003033	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGTTCTGGCCCTTCGGTAGCCGCGGCCGACCGGGACGTCACGGCTGTGGCCGACGTCCCCCGGCGCATGATGGAGGCGTGGGCGTCCAACGACGCCTCCGCCTTCGCGAGCCTCTTCGCCCCGGACGGGACCATGGTGCTTCCCGGCGACGTCTTCCAGAAGGGAGTCGACGGGATTCGGGAGTTCATGACCAAGTGCTATGCCGGTCCGTACAAGGGCACCTCGGTTTTCGGAGTGCCCATCGACGTAAGGTTCACCGGCCCCGACACGGCGATCCTGATCACTCAGGGCGGAGTCATGGCTCCTGGGGAGCACTCGGTCGCCCCCGACAAGGAGATCCGGGCCACGTGGGTGCTCGGCAAGCGTGACGGTGCGTGGCTCGTCGAGGCCTACCACAACAGCCCCGTCCGTCTGCCATGA	MSSGPSVAAADRDVTAVADVPRRMMEAWASNDASAFASLFAPDGTMVLPGDVFQKGVDGIREFMTKCYAGPYKGTSVFGVPIDVRFTGPDTAILITQGGVMAPGEHSVAPDKEIRATWVLGKRDGAWLVEAYHNSPVRLP	MARFFIDRPVFAWVISLLIVLAGVLAIRFLPVAQYPDIAPPVVNVSATYPGASAKVVEEAVTAIIEREMNGAPGLLYTKATSSTGQASLTLTFRQGVNANLAAVEVQNRLKIVESRLPESVRRDGIYVEKAADSIQLIVTLTSSSGRYDAMELGEIASSNVLQALRRVEGVGKVETWGAEYAMRIWPDPAKLTSMNLSASDLVNAVRRHNARLTVGDIGNLGVPDSAPISATVKVDDTLVTPEQFGEIPLAHPRDGGAIRLRDVARVEFGQSEYGFVSRVNQMTATGLAVKMAPGSNAVATAKRIRATLDELSRYFPEGVSYNIPYDTSAFVEISIRKVVSTLLEAMLLVFAVMYLFMQNFRATLIPTLVVPVALLGTFTVMLGLGFSINVLTMFGMVLAIGILVDDAIIVVENVERLMAEEGLSPHDATVKAMRQISGAIVGITVVLVSVFVPMAFFSGAVGNIYRQFAVTLAVSIGFSAFLALSLTPALCATLLRPIDADHHEKRGFFGWFNRAFLRLTGRYRNAVAGILARPIRWMLVYTLVIGVVALLFVRLPQAFLPEEDQGDFMIMVMQPEGTPMAETMANVGDVERYLAEHEPVAYAYAVGGFSLYGDGTSSAMIFATLKDWSERREASQHVGAIVERINQRFAGLPNRTVYAMNSPPLPDLGSTSGFDFRLQDRGGVGYEALVKARDQLLARAAEDPRLANVMFAGQGEAPQIRLDIDRRKAETLGVSMDEINTTLAVMFGSDYIGDFMHGSQVRKVVVQADRRKRLGIDDIGRLHVRNEQGEMGAAGDVRQGRLDPRPAATDPLQRLSLVQPRGPGRAGLQQREAMQAMEQLMQGTARGIRPRVVRPVLRRTPVAGAQAPALFALSVLIVFLALAALYESWSIPLAVILVVPLGVLGALLGVSLRGLPNDIYFKVGLITIIGLSAKNAILIIEVAKDHYQEGMSLLQATLEAARLRLRPIVMTSLAFGFGVVPLALSSGAGIRAQVAIGTGVLGGIVTATVLAVFLVPLFFLVVGRLFRLRKAPRTGNSPQIPTEQA	13.38	gnl|BL_ORD_ID|1640|hsp_num:0	1786			873	927	erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; meropenem; chloramphenicol; arbekacin; norfloxacin; ofloxacin; gentamicin
BGC0000112.1|Neocarzinostatin_8 # 6658 # 11964 # -1 # ID=1_8;partial=00;start_type=TTG;rbs_motif=AGGA;rbs_spacer=8bp;gc_cont=0.705	BGC0000112.1|Neocarzinostatin_8 	6658	11964	-	Loose	1800	28.1054	mexY	51.72	3003033	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGACGGAATACGCAGCACCCGACGAAGCAATCGCCATTATCGGTATGAGTTGCAGGTATGCCCCGGATCTCGACTCGCCGGACAAGTTCTGGGACTTCCTTGTCAACGGCAGAAGCACCGTCGGTGACATGCCTGACAAACGGTGGGAACCCTACGCATCGGGCAGCCCGCAGGCGACCGCGGCGATGAGGGACACCGTTCGCCGCGGCGCGTTCCTCGATGACATCGAAGGCTTCGACGCCGAGTTCTTCGGAATCTCGCCCAGGGAAGCCGACTTCCTGGATCCCCAGCAGCGCTTCATGCTCGAGCTCGCCTGGGAAGCCCTGGCCGACGCCGGTGTTCCCCCGCTGACTCTGCGCAACACCGACACCGGCGTGTACGCCGCCGCGAATTCCAACGACTACGGCAGGCGGCTCCTGGAGGACATCCCGCGTACCGGTGCCTATGCGGTGAACGGCACGACGCTGTACGGCATCGCCAACCGCGTCTCCTACTTCCTGGACCTCCACGGACCGAGCATGGCGGTCGACACGGCCTGCGCCGGAGCGCTGACGGCTCTTCACCTCGCCCGTCAGAGCCTGCTGACCGGGGAAACGCCCCTGGCGATCGTCGGCGGTCTCAACATCATGTCCACTCCCTCCCTCAACGTGGCCCTCAACGACGCCGGAGCCATGTCCCCCGACGGCCGCAGCAAGGCCTTCGACGAGGACGCCGACGGGTACGGCCGCGGTGAGGGGGCAGGGGTTCTCGTACTCAAGAGGCTGTCCGACGCACGGCGCGACAACGATCCCGTCCACGCGGTCATTCGTGGCAGCGGTGTCTTCCAGGACGGCCGTTCCGACGGCATGATGGCGCCGGACGGGGACGCCCAGGAGCACATGCTCCGGCAGGCGTACCACCGGGCGGGGGTGGACCCGGCCACAGTGGACTACGTCGAGGCGCACGGCACGGGAACACCCACTGGTGACCGTGAGGAGATCACCGCCCTCGCCAAGGTGTTCGGAGCAGGCCGGTCACCCCATGCCCCCTGCCTGATCGGATCGGTGAAGCCCAACGTCGGTCACGTCGAGGGCGGCTCCGGCATCACCGGCGTGATCAAGACGGTCCTCGCGCTGAGGAACGAGCTGATCCCCCCCACCCTCCACGACCGGCCCCGTACCGACGTCGACTGGGACGCCTGGGGGGTGCGCCTGGTCGGGCAGGTACAGGAGTGGCCCTCCTGCGGACGGCCCCGGCGCGCGGGAGTCTCCAGCTACGGCGTCGGGGGCACGATCTCCCACGTGATCCTGGAGGAGAGCCCGGTGCCGGCGGCGACCTCGTCCGCCGACGCCTCCACAGGCGTACGGACGCCCGCACTCTTCCCGCTCTCGGCCGCCTCGGAGGCGGGACTGCGCGCGCTGGCGGGCGAGGCCGCAGGCTGGGTGGCCTCTCGTCCTGACACCCCGCTGCCGTCGGTCGGACACACCCTGACTCAACGGCGCTCGCACCTTGCTCAGCGTGCCGCGGTCGTCGCGGACTCCGCCGAGCAACTCGTCGACCGGCTGCGCGAGGTCGCTGAGGGACGCAACGGCCCCGGCATCGTGTCGGCACGCACCAGTGCGGGGCGCGCTGACGACGCCGTCTGGGTCTTCTCCGGGCATGGTGCCCAGTGGTCCGGAATGGGCCGCCGACTGCTGGCGAGCGAGCCGGTCTTCGCGGCGACCCTCGACGCGCTGGACGAGGTGTTCCGCGAGGAACTCGGCTGGACGCCCCGGGAGGCGGTCACGGAGGGCGGACCGTGGACTGCCGCTCATGTCCAGGCACTGACCTTCGCCGTCCAGATCGGGCTGGCTGACGTGTGGCGCAGCAAGGGCCTGCGGCCGGGCGCGGTCATCGGGCATTCCGTCGGTGAGATCGCGGCTGCGGTGGTGGCCGGGTCCCTCGACCGTGATGAGGCCGCCCGTTTCGCGTGTCGCCGTGCGGCGGCGCTCCAGAGGCTCGACGGGCGGGGCGCCATGGTCATGGTCGGGCTTCCGTTCGAGGAGGCGGCCCTGCGCCTTGGAGACAGGCGGGACGTGGAGGCCGCCATCTCGGCGGGACCGCATTCCACGGTCCTGTCCGGTGACCGTTCGGCGGTTCTGCGCGTCGCCGAGGAGTGGCAGGCCTCGGAGGTGTGGACGCGGACCGTCGACTCCGACATCGCTTTTCACAGCGTCCACGTCGACGAGGTGACTGGCGACATCGAGTCGGCCGCACGCCTGCTCACGCCCCGGCCGCCGACCGTCCCCCTCTACACCACCGCCCTGTCCGACCCGCGGTCGCGGGCTCCGCGCGACAGCGGCTACTGGGCGGCGAACCTGCGCAAGCCGGTCCGCTTCACCGAGGCCGTACGCGCGGCCGCCGAGGACGGCCACCGACTGTTCCTCGAGGTGTCCAGCCACCCGGTGGTGGCCCATTCGGTCAGCGAGACGCTTTTGGACCTCGGCATCGAGGACGCCGCGGTGGCCGGGACACTGCGGCGCGACACCGACGAGGTGGAGTCGCTGCTGGAAAACCTCGCCGAACTGCACTGCCACGGCGTGGCCGTCGACTGGGCGCGCCATCACACCGACGGCGAGCTCGTGGGACTGCCGGCGGCCGTGTGGCAGCACCGGCCCTACTGGATCTTCCCCGAGACCACCGCCGACGCGGGTCTCGGCCGTGGGCACGATCCCGCGAGCCACAGCCTGCTCGGCGGCCGGATGACCGTCAGCGGCTCACCGACCAGGCAGGTGTGGCAAACCCGGCTCGACATGGACAGCCGGCCCTACCCGCAGAGCCACGGGCTCGTCGGTGTCGAGGTCACCCCCGCGGCGTCCATCATCAACACCTTCGCCGCAGCTGTGGAGGAGGACGGTCCGTCCGCTTTGACGGACATCGTGCTGCGTACGCCCCTGGCGGTGGAACCGCCTCGGGTGGTCCAGGTGGTGCGCGAAGGAAGGTCGCTGTCGCTCGCCACCCGCGTGGCCGAGGACGCCGACGCCGACGGGAGCGAGTGGATCACGCACACCACGGCCGCCGTCACGCCGGGGGTCCGCCCGGCCGGCGGGCGGCTGGACACGGAAGCCATCCGCTCTCGGCTCCCGGAGGGATCGCTCACCAGGGCCGACGAGATGTTCGAGCGCATGGGGGTCGAGGGCTACGCCTTCCCGTGGGACCTGGAGGAGCTGCGCCACGACGACCATGAGCAGCTCGCCGTACTGCAGATCGAGCCCTCGCCGGCCCAGAGGGCGACCAGCTGGGCCCACGTCATCGACGGCGCGCTGACCATCAGCGCCATGGTGGTCTCCCCAGGGGACGCCACCGTGCTCTGGATGTCCCGGTCCATCGATCAGGTGACGTGGTCGGGTGAGCCGCCCGCCAGGCTCACCGTGCACAGCACCCGTTCGCTCCGGTCACCGCACGACACGGTCGACGTGCGGGTCGCCGACGAACGGGGGGACGTCGTCTGCGAGGTCGTCGGGCTCCGATTCGCGGCCGTCGAACACATCGGCGCCGCGGTATTGCCCAGCGAACTGGTGCACGAGATCGTGTGGCGCCCCTGGGACCCGGAGGACCACGAGGGTGCTGAGGATGCGCCCGTGGAGCAGGTGATCCTCGTCGGGGATCCCGAGGCCACCGTTCCTCTCGCCGAACAACTCGAGTCGGCCGGCATGACCTGCGTACAGGTGGGCGACTCACCGGAGACGGGGCTGCGGCCCGACCTGTTCGCCCGGCCGGGCGCGGTGGTCGTTGCGCCCGCTCTGGCCGGTTCGGACACGGCGCCGGAGGAGGAGGCGGAGCGCGTGTCGTGGCTGCTCGTACGGACCGTGCAACGTGTCGCCGAGATCCGGGCCGACGTCACCGGGGACGCACCGGCGCAGCGGGTGTGGTGCGTCACCAGCGACGTCCGACGGGCCCGTGACGAACGGTCTGTGGCGCACGGGCCGCTGTGGGGCCTGGCTCGCATCGTCGCGGGAGACCATCCCGAACTGTGGGGCGGGGCCGTCGACATCGGGCCGTCGGCCGACGGCATCGGCGCGCGTCTGGTCGCACTGCTGGACGGTGCCGCCGGTACGGAGGATGTCATCTCGCTGACGGGCGAGGGAGCCGAGGTCGCCCGGCTGAGCCGCATCGACCGCAGTGCGGACGGTACGCCGCTGCAGTGTTCGCCCTCGGGCACCGTCCTGATCACCGGCGGCCTGGGCGCTCTGGGACTGGAGGTCGCGAGGTGGCTGGTGGACCGGGGCGCCCGTCGGCTCGTGCTCGTCAGCCGCCGTGCCCTGCCCAACCGTACCGAGTGGCCTGCCGTCACCGACGCCGAGACCAGGCGCAGGATCGACGGCGTGCTGGCGCTCGAGGCACTCGGCGTCACGGTCCGGGTGCTCGCGCTCGACATCACGGACGTCGACCAGGTGTCGGCGGCACTGGCGCCGGAAGCGCTCGGTCTGCCGCCGGTGCGGGGAGTCGTGCACGCTGCAGGTGTCGTGAACAACGCCCTGGTGGACAAGGTCGACCTCGAGGGACTGCGAGAGGTGCTGGCCCCGAAGGTCCGTGGCGCCATGGTGCTGCACCGCCTCTTCCCACCCGGTGATCTCGACTTCTTTGTGTTGTTCTCCTCCTGCGGCCAGTTCGCCCGTCTGTCGGGCCAGGCCAGTTACGCCGCGGCCAACTCGTTCCTGGACACGCTCGCGAGCCACCGCAACGCGGGAGAGCACACCGAGACGGTCAGCCTGGGCTGGACGGCCTGGCGTGGGCTGGGCATGTCCTCGAACATCGACACCACGATGTTCGAGGCCAACTCGCGAGGCCTGGAAGCCGTCTCCGCGACCGAGGCGTTCGGCGCGTGGTCCTTCGGCGACAGGTTCCAGTCCGACTACCAGGCCATACTCCGGGTGGTGCCGACCCCCGTGCACACACCTCGCCTGCCGGTGTTCCGGGACCTGCCCGTCTCCGGCGAGACGGACGGCCCCACGGGCGACCAGCTCTTCACCACCACTCTGGAAGGGCTTCCGGAGCAGGAGGCACGCGAGAGGATCACCGCCGATGTGCGCGAACAGGTGGCCGGAGTGCTCAACTTCGACCCCTCTGAAGTAGAGGTCAAGCGCCCCCTCGTCGAGCTCGGAGTCGACTCAGTGATGACGGTCGCTCTCCGGGTGCGCCTGCAGCGTCGGTACGGCCTCGAGCTTCCGCCGACGATTTTGTGGGCCAAGCCGACTGTGGCGGCCCTCTCCGAACATGTCTGCGACAGCCTGCGTTGGGACGGGGAGGAGCACGGGGATCTGGCTGCGCCGACCGCGGCGGCGTAG	MTEYAAPDEAIAIIGMSCRYAPDLDSPDKFWDFLVNGRSTVGDMPDKRWEPYASGSPQATAAMRDTVRRGAFLDDIEGFDAEFFGISPREADFLDPQQRFMLELAWEALADAGVPPLTLRNTDTGVYAAANSNDYGRRLLEDIPRTGAYAVNGTTLYGIANRVSYFLDLHGPSMAVDTACAGALTALHLARQSLLTGETPLAIVGGLNIMSTPSLNVALNDAGAMSPDGRSKAFDEDADGYGRGEGAGVLVLKRLSDARRDNDPVHAVIRGSGVFQDGRSDGMMAPDGDAQEHMLRQAYHRAGVDPATVDYVEAHGTGTPTGDREEITALAKVFGAGRSPHAPCLIGSVKPNVGHVEGGSGITGVIKTVLALRNELIPPTLHDRPRTDVDWDAWGVRLVGQVQEWPSCGRPRRAGVSSYGVGGTISHVILEESPVPAATSSADASTGVRTPALFPLSAASEAGLRALAGEAAGWVASRPDTPLPSVGHTLTQRRSHLAQRAAVVADSAEQLVDRLREVAEGRNGPGIVSARTSAGRADDAVWVFSGHGAQWSGMGRRLLASEPVFAATLDALDEVFREELGWTPREAVTEGGPWTAAHVQALTFAVQIGLADVWRSKGLRPGAVIGHSVGEIAAAVVAGSLDRDEAARFACRRAAALQRLDGRGAMVMVGLPFEEAALRLGDRRDVEAAISAGPHSTVLSGDRSAVLRVAEEWQASEVWTRTVDSDIAFHSVHVDEVTGDIESAARLLTPRPPTVPLYTTALSDPRSRAPRDSGYWAANLRKPVRFTEAVRAAAEDGHRLFLEVSSHPVVAHSVSETLLDLGIEDAAVAGTLRRDTDEVESLLENLAELHCHGVAVDWARHHTDGELVGLPAAVWQHRPYWIFPETTADAGLGRGHDPASHSLLGGRMTVSGSPTRQVWQTRLDMDSRPYPQSHGLVGVEVTPAASIINTFAAAVEEDGPSALTDIVLRTPLAVEPPRVVQVVREGRSLSLATRVAEDADADGSEWITHTTAAVTPGVRPAGGRLDTEAIRSRLPEGSLTRADEMFERMGVEGYAFPWDLEELRHDDHEQLAVLQIEPSPAQRATSWAHVIDGALTISAMVVSPGDATVLWMSRSIDQVTWSGEPPARLTVHSTRSLRSPHDTVDVRVADERGDVVCEVVGLRFAAVEHIGAAVLPSELVHEIVWRPWDPEDHEGAEDAPVEQVILVGDPEATVPLAEQLESAGMTCVQVGDSPETGLRPDLFARPGAVVVAPALAGSDTAPEEEAERVSWLLVRTVQRVAEIRADVTGDAPAQRVWCVTSDVRRARDERSVAHGPLWGLARIVAGDHPELWGGAVDIGPSADGIGARLVALLDGAAGTEDVISLTGEGAEVARLSRIDRSADGTPLQCSPSGTVLITGGLGALGLEVARWLVDRGARRLVLVSRRALPNRTEWPAVTDAETRRRIDGVLALEALGVTVRVLALDITDVDQVSAALAPEALGLPPVRGVVHAAGVVNNALVDKVDLEGLREVLAPKVRGAMVLHRLFPPGDLDFFVLFSSCGQFARLSGQASYAAANSFLDTLASHRNAGEHTETVSLGWTAWRGLGMSSNIDTTMFEANSRGLEAVSATEAFGAWSFGDRFQSDYQAILRVVPTPVHTPRLPVFRDLPVSGETDGPTGDQLFTTTLEGLPEQEARERITADVREQVAGVLNFDPSEVEVKRPLVELGVDSVMTVALRVRLQRRYGLELPPTILWAKPTVAALSEHVCDSLRWDGEEHGDLAAPTAAA	MARFFIDRPVFAWVISLLIVLAGVLAIRFLPVAQYPDIAPPVVNVSATYPGASAKVVEEAVTAIIEREMNGAPGLLYTKATSSTGQASLTLTFRQGVNANLAAVEVQNRLKIVESRLPESVRRDGIYVEKAADSIQLIVTLTSSSGRYDAMELGEIASSNVLQALRRVEGVGKVETWGAEYAMRIWPDPAKLTSMNLSASDLVNAVRRHNARLTVGDIGNLGVPDSAPISATVKVDDTLVTPEQFGEIPLAHPRDGGAIRLRDVARVEFGQSEYGFVSRVNQMTATGLAVKMAPGSNAVATAKRIRATLDELSRYFPEGVSYNIPYDTSAFVEISIRKVVSTLLEAMLLVFAVMYLFMQNFRATLIPTLVVPVALLGTFTVMLGLGFSINVLTMFGMVLAIGILVDDAIIVVENVERLMAEEGLSPHDATVKAMRQISGAIVGITVVLVSVFVPMAFFSGAVGNIYRQFAVTLAVSIGFSAFLALSLTPALCATLLRPIDADHHEKRGFFGWFNRAFLRLTGRYRNAVAGILARPIRWMLVYTLVIGVVALLFVRLPQAFLPEEDQGDFMIMVMQPEGTPMAETMANVGDVERYLAEHEPVAYAYAVGGFSLYGDGTSSAMIFATLKDWSERREASQHVGAIVERINQRFAGLPNRTVYAMNSPPLPDLGSTSGFDFRLQDRGGVGYEALVKARDQLLARAAEDPRLANVMFAGQGEAPQIRLDIDRRKAETLGVSMDEINTTLAVMFGSDYIGDFMHGSQVRKVVVQADRRKRLGIDDIGRLHVRNEQGEMGAAGDVRQGRLDPRPAATDPLQRLSLVQPRGPGRAGLQQREAMQAMEQLMQGTARGIRPRVVRPVLRRTPVAGAQAPALFALSVLIVFLALAALYESWSIPLAVILVVPLGVLGALLGVSLRGLPNDIYFKVGLITIIGLSAKNAILIIEVAKDHYQEGMSLLQATLEAARLRLRPIVMTSLAFGFGVVPLALSSGAGIRAQVAIGTGVLGGIVTATVLAVFLVPLFFLVVGRLFRLRKAPRTGNSPQIPTEQA	169.02	gnl|BL_ORD_ID|1640|hsp_num:0	1786			1755	1842	erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; meropenem; chloramphenicol; arbekacin; norfloxacin; ofloxacin; gentamicin
BGC0000112.1|Neocarzinostatin_9 # 12383 # 14059 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.704	BGC0000112.1|Neocarzinostatin_9 	12383	14059	+	Loose	1000	62.003	almE	22.7	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGCACGAGACAGCAGCAGCACCGGCCCCCGCAGGATTCGTCCCCTGGCCCGACGATGTGGCAGCCCGCTATACGGCCGCCGGCCACTGGGAGGGACGCTCGCTGGGGACGCACCTGGCGGAGGCCGCACGGAAGGTCCCAGAGGCCGTATGCCTCGTCGACGGTCCGGTCCGTATGAGCTACAGCGAGTTGATGGCACGCGCGGACGGGGCGGCCGTCCGTATGAGAGGGCTCGGCATTCGCCCGGCCGACCGGGTGGTGGTGCAGCTACCCAACTGCTGGGAGCACGTGGTCGTGACCATGGCGTGCCTGCGGCTCGGCGCTCTGCCGATCTGGGCGCTGCCGCAGTACCGGCACCGCGAACTGTCGGGCGTGGTGACTCACGCCCGGGCCAGTGCCCTCGTCGTGCCCGACGTGTACCGGGAGTTCGACCACCAGGCGCTGGCGCACGAAGTGGCGGAGGCGCAGCCGACTGTCCGGCACGTCCTCGTGGCGGGGTCCGACGTACGGCCGGACAGCGTCGATCTGCGCGCGCTGTGCGAGCCTCTGGACGCGGACGAGGCCGCGCGGGTCGCGGCCGAGCTCGACCGGTCCGCGCCGCGTGGTGAGGAGGTCGCGATGCTCAAGCTGTCCGGCGGGACGACCGGACTGCCCAAGCTCGTGGCACGCACGCACAACGACCTCAGCTACATGATCAAGCGCGCTGCCCAGGTGTGCGGCTTCGGACGGGACACGGTGTACTTGGCCGTCCTGCCGCTCGGTCACGGCTTCCCCAACACCGGTCCCGGAGTCCTCGGCACGCTCCTGGCCGGGGGGCGGGTGGTGATTTCCGGATCGCCGGCTCCCGAGGCCGCTTTCGCGCTGATGGAGCGGGAACGGGTGACCGCCACGTCCGTGGTGCCGGCCATTGTCATGCGGTGGCTCCAGTACCGGGACGAGCGGCCGGGCGCCGACCTGGGTTCGCTGGAGCTCATGCAGGTCGGGGCCTCGCGGCTCGAGCCGGAGGTGGCCCGGCAGGTGGGACCGAAACTGGGCTGCAGGCTGCAGCAGGTGTTCGGGATGGCGGAGGGCCTGCTGTGCCTGACCCGCCTGGACGATCCGGACGACGTGGTCCACTACACCCAGGGACGGCCGATCAGCCCGGACGACGAGATCCGGGTGGTGGACCCGGAGGGCAGGACAGTGGGTGTGGGCGAACCCGGGGCGTTGCTCACGCGGGGGCCGTACACGCCGCGCGGCTACTACGATTCGCCCTCCGCCAACGCGCGAGCGTTCACCCCCGACGGCTGGTACCGGACCGGTGACCTGGTACGCCGGACGCCGGACGGCAACCTGATCGTGGTCGGCAGGGAGAAGGACCTCATCAACAGGGGTGGCGAGAAGATCAACGCCGAGGAGGTGGAGGGCTTCGCGGTGCAGGTCGACGGAGTTCTGCAGGCGGCTGCCGTCGGCCTGCCGGACAGCGAACTCGGCGAGCGGATCTGTCTGTTCGTCGTGCTGGCCGACGGCACGCGGGTGGAGCTGGCGGACGTCCGGAAGGTGATGGAGAACGCCGAGACGGCGTCGTTCAAGCTTCCGGAGCGTCTCATCACGCTTCCCTCCCTGCCCACCACACCGATGGGCAAGATCGACAAGAAGGCACTGCGTGCTGCCGCCGGTCGGATGTCCGAAACCTGA	MHETAAAPAPAGFVPWPDDVAARYTAAGHWEGRSLGTHLAEAARKVPEAVCLVDGPVRMSYSELMARADGAAVRMRGLGIRPADRVVVQLPNCWEHVVVTMACLRLGALPIWALPQYRHRELSGVVTHARASALVVPDVYREFDHQALAHEVAEAQPTVRHVLVAGSDVRPDSVDLRALCEPLDADEAARVAAELDRSAPRGEEVAMLKLSGGTTGLPKLVARTHNDLSYMIKRAAQVCGFGRDTVYLAVLPLGHGFPNTGPGVLGTLLAGGRVVISGSPAPEAAFALMERERVTATSVVPAIVMRWLQYRDERPGADLGSLELMQVGASRLEPEVARQVGPKLGCRLQQVFGMAEGLLCLTRLDDPDDVVHYTQGRPISPDDEIRVVDPEGRTVGVGEPGALLTRGPYTPRGYYDSPSANARAFTPDGWYRTGDLVRRTPDGNLIVVGREKDLINRGGEKINAEEVEGFAVQVDGVLQAAAVGLPDSELGERICLFVVLADGTRVELADVRKVMENAETASFKLPERLITLPSLPTTPMGKIDKKALRAAAGRMSET	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	100.36	gnl|BL_ORD_ID|4935|hsp_num:0	5928			579	1662	colistin A; colistin B
BGC0000112.1|Neocarzinostatin_10 # 14119 # 16311 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.694	BGC0000112.1|Neocarzinostatin_10 	14119	16311	-	Loose	500	27.7202	PER-13	25.0	3006134	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; penam; penem	antibiotic inactivation	PER beta-lactamase	ATGTCTTCCGTTACGCACGGCTCCCCGTCGGTGACCGCGTCCCCTCCGGATCCGGTGCCCTTTGTCCGGAACGACCGGAGCCGGACGAAGGCATGGGCACTGGCCGGGATCTGTGGGCTCGCGGGCCTGCTCTACCTGTGGCTCATCGGCTCCAGCAACTACGGCAACGCCTACTACTCCGCCGCAGTGCGGTCGATGACGGAGAGTCCGACCAACTTCCTGTTCGGCGCGGCGGACCCGTATGGCGCCGTCTCGGTCGACAAGCCCCCGCTGGCACTTTGGCCCCAGGCGGCGTCGGTGGCGGTCTTCGGGTACCACAGTTGGTCGATGCTGCTTCCCCAGGCCGTCGAAGGCGTGGTCACCGTGTTCCTGCTGCACCGCACGGTCCGCCTGTGGGCGGGGGAACGCGTCGCGCTGCTCGCGGCACTGATCCTCTCGCTGACCCCCATCACCGTCGCCATCAACCGCGACAACAACACCGATTCCCTTCTGATGATGCTGCTGGTCGCGGCGGCGTACTCGTTCACCCGCTCGATCCACGCCGGGACGGACCGTGGCCGCACCAAGTGGCTGCTGCTGTGCGCCTTCTTCGTGGGCTGCGGATTCACGGCGAAGATGCTGCAGGCGTGGATCATCGTGCCGGTACTGGCTCTCGCGTTCCTACTCAGCAGCACCAGCCCGGTGAGACGCAGGATCAACGACGTCCTGGCCGCGGGTGCCGTACTGGTCGTCTCCTCGTTCTGGTGGCCCGCATTGCACGATTTGTGGCCGGGTGACAAGCCCTACATGGGCGGCAGCACGGACGGGAGCGCGTTCCAGCTCGTCTTCGGCTACAACGGGTTCGGCGCGCTGTTTGGCACCGGCCAGCAGCCCGGCGGCTCCGGGATCAACGTGCCCCTCGCGATGGTCGGGCTCTCCGGCGGAATGCCCGGGGTCACCCGCATGTTCTCTGCCGAGGTCGGTGACCAGATCTCCTGGTTGCTCCCTCTCAGTCTGCTGGTGCTGACCGTCGTGGGAGCCGCCGGCTACCGCCGCCTGTGGTTCGAGGCCCCGGGTGATGCCGTGCAGCGGGCGGGCTGGCTCCTGTGGGGCGGATGGCTGGTGCTCGTCGGCGGAGTCTTCAGTTTCACTCAGGGCATCTTCAACACGTACTACACGACGATGCTGGCGCCCGCGATCGCCGCGGTCTCCGCGGCGGGTATCGCCCTGCTCTGGCGGAAATACTGCCGGCCGGACGGCTGGCAGTGGATGCTCCTGCCGGCCGCGGTCGCGCTCACAGCACTCTGGGCTTTCGTCCTGGTCTCCAGGGACACCTCGTGGCACGGCTGGACCAGGTGGGCGGCCCTGGGACTCGCCGCCTTCGCGGTCCTCGTCCTGGTGGTGGCCAAACTGTCGCCGGGACGGCGTCCCCTGGGACACGCCGGGCTGGTCGTCGGGGCGGCAGCGGTGCTGCTGTCCCCAGCAGTGTGGTCCGTGGGCACCGCGGCCGTGGCAGCCGACAATGGCGGCTTCCCCACGGCGGGTCCGCCGAACAACGCGTTCAGCGCCCTGCTGCGCGGGGAACTCCCTGACGGCATGATGCCGCCCGCTGGCATGCCCCCGGGCGGGGGCCAGATGCCCGAGGGCATGGAACTGCCCCCCGGTCTGCAACTGCCCGAGGGCGCGCAGATGCCCGGTGGCATGCAGATGCCCGATGGCGTCCCGGCATCCGGTGAGGACACCGCCGCATCTTCCGGCGTCCGGAGCGGGAAGGGCTTCGGCGGCTCCGACCTCTCCGCCGGCAATCGGCGGATCCTCGAGTACGCCGAACGCCACTCTGGCGGTGCCGGCGTCACACTCGCCGTCGAGGGCGGCGGGCTCGCTTCGTCGTCCTTCATCATCGAGACCGGTGCCCCGGTCGTCGGCATGGGCGGATTCCTGGGCGCCGACGACTCACCCACCGTCGACCAGCTCAGCGAGTGGGTCGACCGAGGGGACCTGAGGTTCGTTCTCACCGCCCATCCTGGCAAAGCGCGGCTGGGCGGCATGGCCGGGATGGGCGGCAGCGTGCAGCAGAAGCGGTTGGTCTGGGTGCGCGAGAACTGCCGACTCGTCGACCCCGGCGCGTACGGCGGCGAGCCCTTCGACGAGAAGCAGGCTCAGCTGCCGGTACCAGGGTTCAGCGACGCAGCGCTGTATCGCTGCGGAGCGTGA	MSSVTHGSPSVTASPPDPVPFVRNDRSRTKAWALAGICGLAGLLYLWLIGSSNYGNAYYSAAVRSMTESPTNFLFGAADPYGAVSVDKPPLALWPQAASVAVFGYHSWSMLLPQAVEGVVTVFLLHRTVRLWAGERVALLAALILSLTPITVAINRDNNTDSLLMMLLVAAAYSFTRSIHAGTDRGRTKWLLLCAFFVGCGFTAKMLQAWIIVPVLALAFLLSSTSPVRRRINDVLAAGAVLVVSSFWWPALHDLWPGDKPYMGGSTDGSAFQLVFGYNGFGALFGTGQQPGGSGINVPLAMVGLSGGMPGVTRMFSAEVGDQISWLLPLSLLVLTVVGAAGYRRLWFEAPGDAVQRAGWLLWGGWLVLVGGVFSFTQGIFNTYYTTMLAPAIAAVSAAGIALLWRKYCRPDGWQWMLLPAAVALTALWAFVLVSRDTSWHGWTRWAALGLAAFAVLVLVVAKLSPGRRPLGHAGLVVGAAAVLLSPAVWSVGTAAVAADNGGFPTAGPPNNAFSALLRGELPDGMMPPAGMPPGGGQMPEGMELPPGLQLPEGAQMPGGMQMPDGVPASGEDTAASSGVRSGKGFGGSDLSAGNRRILEYAERHSGGAGVTLAVEGGGLASSSFIIETGAPVVGMGGFLGADDSPTVDQLSEWVDRGDLRFVLTAHPGKARLGGMAGMGGSVQQKRLVWVRENCRLVDPGAYGGEPFDEKQAQLPVPGFSDAALYRCGA	MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLLINPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDEFSVPVQQLLQYSVSHSDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQVQYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTSGPERLKGLLPAGTVVAHKTGTSGIKAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQTAYQFELKKLSALSPN	237.01	gnl|BL_ORD_ID|4546|hsp_num:0	5616			336	615	
BGC0000112.1|Neocarzinostatin_11 # 16278 # 16382 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.581	BGC0000112.1|Neocarzinostatin_11 	16278	16382	-	Loose	1000	22.3274	MCR-3.7	38.71	3004510	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGAGGGTGTTCCGCGTGCCCCTCATCAGCTGCCGACGGGGCGTATCAAAGATGAAAGGGATGAGAAAAGCATGTCTTCCGTTACGCACGGCTCCCCGTCGGTGA	MRVFRVPLISCRRGVSKMKGMRKACLPLRTAPRR	MPSLIKIKIVPLIFFLALYFAFMLNWRGVLHFYEILYKLEDFKFGFAISLPILLVAALNFAFVPFSIRYLVKPFFALLIALSAIVSYTMMKYRVLFDQNMIQNIFETNQNEALAYLSLPIIGWVTIVGFIPAILLFFVEIEYEEKWFKGILTRVLSMFASLIVIAVIAALYYQDYVSVGRNNSNLQREIVPANFVNSTVKYVYNRYLAEPIPFTTLGDDAKRDTNKSKPTLMFLVVGETARGKNFSMNGYEKDTNPFTSKSGGVISFNDVRSCGTATAVSVPCMFSNMGRKEFDDNLARNSEGLLDVLQKTGVSIFWKENDGGCKGVCDRVPNIEVKPKDYPKFCDKNTCYDEVVLQDLDSEIAQMKGDKLVGFHLIGSHGPTYYKRYPDAHRQFTPDCPRSDIENCTDEELTNTYDNTIRYTDFVIAEMIAKLKTYEDKYNTALLYVSDHGESLGAMGLYLHGTPYKFAPDDQTRVPMQVWMSPGFTKEKGMNMECLQQKAADTRYSHDNIFSSVLGIWDVKTSVYEKGLDIFSQCRNVQ	6.28	gnl|BL_ORD_ID|2673|hsp_num:0	3138			1425	1518	colistin A; colistin B
BGC0000112.1|Neocarzinostatin_12 # 16379 # 17092 # -1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.662	BGC0000112.1|Neocarzinostatin_12 	16379	17092	-	Loose	2090	25.7942	cmeB	36.11	3000784	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; cephalosporin; fusidane antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCACGCAGTGATCCTGGCGGGCGGCAAGGGGACGAGGCTGCGGCCGTACACCAGCCGGCTGCCCAAACCCCTGGTGCCGATCGGTGACGAGTTCTCGATCCTGGAGATCGTCCTGAGCCAGCTCTCCCAGCGGGGATTCGACACGGTGACGCTCGCCATCGGCTACCTCGGCCACCTGATCCGTTCCTTCGTGGGCGACGGCAGCCGATGGAACATGCACATCACCTACGCCTCGGAGGACACGCCCCGGGGGACGATCGGCCCGGTCCTGGGCATCCTCGACCAACTGCCCGAACACTTCCTGGTCATGAACGGTGACATCCTCACCGACCTGGACTACGCCGATGTGCTGGCCCATCACACCAGGGGTGAGGCGCCGCTGACGGTGGCGACGTGCACGCGCGAGGTGCGTATCGACTTCGGCGTGCTGACGACGACCAGCAACCGGGTGGTCCACTTCGTGGAGAAGCCGACGGTCGACTACCGGGTCAGCATGGGGGTCTACGGCCTGAGCCGCACCACCCTCGAAACCTATCCGTCCCACATGCCGTTCGGCTTCGACGACCTGGTCCTCGACCTGCTGGCCCGCGGTGTCCAGCCGGCGGAGTACCCCTTCGACGGGTACTGGCTGGACATCGGCCGCCCTGACGACTACGACCGCGCCAACGCCGAGTTCGACTCGATCAAGGGGACCCTGCTCAAGGGGGCATGA	MHAVILAGGKGTRLRPYTSRLPKPLVPIGDEFSILEIVLSQLSQRGFDTVTLAIGYLGHLIRSFVGDGSRWNMHITYASEDTPRGTIGPVLGILDQLPEHFLVMNGDILTDLDYADVLAHHTRGEAPLTVATCTREVRIDFGVLTTTSNRVVHFVEKPTVDYRVSMGVYGLSRTTLETYPSHMPFGFDDLVLDLLARGVQPAEYPFDGYWLDIGRPDDYDRANAEFDSIKGTLLKGA	MFSKFFIERPVFASVVAIIISLAGVIGLTNLPIEQYPSLTPPTVKVSATYTGADAQTIASTVASPIEDAINGADNMIYMDSTSSSSGTMSLTVYFDIGTDPDQATIDVNNRISAATAKMPDAVKKLGVTVRKTSSATLAAISMYSSDGSMSAVDVYNYIALNVLDELKRVPGVGDANAIGNRNYSLRIWLKPDLLNKFKITATDVISAVNDQNAQYATGKIGEEPVTQKSPYVYSITMQGRLQNPSEFENIILRTNDDGSFLRLKDIADVEIGSQQYSSQGRLNGNDAVPIIINLQSGANALHTAELVQAKMQELSKNFPKGLTYKIPYDTTKFVIESIKEVIKTFIEALILVIIVMYMFLKNFRATLIPMIAVPVSLLGTFAGLYVLGFSINLLTLFALILAIGIVVDDAIIVVENIDRILHENEQISVKDAAIQAMQEVSSPVISIVLVLCAVFIPVSFISGFVGEIQRQFALTLAISVTISGFVALTLTPSLCALFLRRNEGEPFKFVRKFNDFFDWSTSVFSAGVAYILKRTIRFVLIFCIMLGTIFYLNKAVPNSLVPEEDQGLMIGIINLPSASALHRTISEVDHISQEVLKTNGIKDAMAMIGFDLFTSSLKENAAAMFIGLQDWKDRNVSADKIAMELNKKFAFDRNASSIFIGLPPIPGLSITGGFEMYVQNKSGKSYDQIQKDVNKLVAAANQRKELSRVRTTLDTTFPQYKLIIDRDKLKHYNLNMQDVFNTMNATIGTYYVNDFSMLGKNFQVNIRAKGDFRNTQDALKNIFVRSNDGKMIPLDSFLTLQRSSGPDDVKRFNLFPAAQVQGQPAPGYTSGQAIEAIAQVAKETLGDDYSIAWSGSAYQEVSSKGTASYAFALGMIFVFLILAAQYERWLIPLAVVTAVPFAVFGSFLLVYLRGFSNDIYFQTGLLLLIGLSAKNAILIVEFAMEERFKKGKGVFEAAVAAAKLRFRPIIMTSLAFTFGVLPMIFATGAGSASRHSLGTGLIGGMIAASTLAIFFVPLFFYLLENFNEWLDKKRGKIHE	22.79	gnl|BL_ORD_ID|689|hsp_num:0	748			15	123	erythromycin; cefotaxime; fusidic acid
BGC0000112.1|Neocarzinostatin_13 # 17107 # 18102 # -1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.674	BGC0000112.1|Neocarzinostatin_13 	17107	18102	-	Loose	1200	75.8702	arnA	29.14	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGGCCGGACTCGTAGCGGTCACTGGGGCGGAGGGATTCATCGGGTCACACCTGGTCGAGACGCTGGTGCGGCGGGGACACCGGGTGCGGGCCATGGTCCAGTACAACTCCTTCGCCTCATGGGGGTGGCTCGACCGGCTCGACGCCGAGGTGATGAGCCACGTGGAGGTGTTCCCCGGCGACGTCCGTGACCCGGCGTCCGTACTGGAGCTGGTCGAGCCGGCCTCGGTCGTCTACCACCTGGCGGCGCTGATCGCGATTCCGTACTCCTACCAGGCGCCGCGTTCATACCTGGACACCAATGTCATGGGCACGATGAATGTGCTGGAAGCTGTACGTGCCACCGGGACACCCAGGCTGGTCCACACCTCGACGAGCGAGACGTACGGCTCGGCGAGGACGGTGCCGATCGGGGAGGACCATCCTCTGCAGGCCCAGTCCCCCTACGCGGCGACGAAGGTGGCTGCAGACAAGCTCGTCGAGTCCTACCACCTCAGCTACGGTGTGCCCGCGGTGACCCTGCGGCCGTTCAACACGTTCGGCCCCCGTCAGTCGGCCCGCGCGGTCATACCCACGATCATCAGCCAGCTTGTCGCAGGGGCCCGGCAGATCACCCTCGGCTCTCTGGCGCCCACCCGTGACTTCACCTATGTCACCGACACAGCGGAGGCCTTCGTCTCGGTCGGCACCGCTCCGGCGTCGGCAGTGATCGGGGAGGTCTTCAACGCCGGCACGGGCACGGAAGTGTCCATCGGACGACTCGCCGCGGACATCATGCGGCTGATGGATGCCGACGCGTCGATCAGGGAGGATCCACAGCGTCTGCGTCCCAAAGACTCCGAGGTCCTACGCCTGGTCTGCGACGCCGGGAGTCTGCGCGCGCGCACGGGATGGCGTCCCCGGACGGACCGCGAGGACGGCCTGCGCCGGACCATCGAATGGTTCCGCAATCCCGTGAACCAGGCCGGCTACAGGCAGACCCACTACAACCGCTGA	MAGLVAVTGAEGFIGSHLVETLVRRGHRVRAMVQYNSFASWGWLDRLDAEVMSHVEVFPGDVRDPASVLELVEPASVVYHLAALIAIPYSYQAPRSYLDTNVMGTMNVLEAVRATGTPRLVHTSTSETYGSARTVPIGEDHPLQAQSPYAATKVAADKLVESYHLSYGVPAVTLRPFNTFGPRQSARAVIPTIISQLVAGARQITLGSLAPTRDFTYVTDTAEAFVSVGTAPASAVIGEVFNAGTGTEVSIGRLAADIMRLMDADASIREDPQRLRPKDSEVLRLVCDAGSLRARTGWRPRTDREDGLRRTIEWFRNPVNQAGYRQTHYNR	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	50.00	gnl|BL_ORD_ID|1513|hsp_num:0	1643			957	1764	polymyxin B
BGC0000112.1|Neocarzinostatin_14 # 18245 # 18964 # -1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.701	BGC0000112.1|Neocarzinostatin_14 	18245	18964	-	Loose	500	29.6462	ErmH	28.05	3002823	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGTCCGCCTGGCTCGAGGAATGGAACAGCAGGCAGGACGTCTACATCGGCGACCGGCACCGGGACCGGCACTTCCGTGCGGTGGCAGGCGACATCGTCCGTCTGCTCCCGCAAGGAGCAAGACGTGTGCTCGACTACGGCCCCGGAGACGCCTTGTCCGCCACGCGCATCGCCGCGGCCTGTGAGGAAGTAGTCCTCTGCGAAGCCGCGGAGACGATCCGGGCCCGGATCTCGGACCGGTTCGCGAACGATCCGGCAATCCGTGTCATCTCGCCGGGGCAGCTCGCGGACCTGGCCGCCGGGTCGGTCGACCTGGTGGTCGTGCACTCGGTGGTGCAGTATCTCGACGCGGACGAACTGGATGCCCTTCTCCGGGAGGTACACCGGCTTCTGGGCGCCGACGGGCTGCTCGTCGTCGGAGACCTCGTCCCCCCGGGAACGGGGCTGGTGTCAGACACGGCCGAGCTGCTGCGCTTCGCCCTGCGCGAGGGTTTCCTCGGGGAGGCGGTGCCGGCCCTCGTGCGGCTGGCGTTCTCCCCCTATGCGCGTCGTCGTCGGCGGCTCGGCCTCACCCGGATCGACGAGGCCGAGATGACGGCCCGAGCGCGGCGGGCTGGCCTCTCCGGTCACCGGGTTCGGCCCAACATCGGCAACAACCAGCGACGTTGGACCTTCGTGGCCAGACGTGCGGCTGCGTCGTCCGTGCGACCGAGCCGATGA	MSAWLEEWNSRQDVYIGDRHRDRHFRAVAGDIVRLLPQGARRVLDYGPGDALSATRIAAACEEVVLCEAAETIRARISDRFANDPAIRVISPGQLADLAAGSVDLVVVHSVVQYLDADELDALLREVHRLLGADGLLVVGDLVPPGTGLVSDTAELLRFALREGFLGEAVPALVRLAFSPYARRRRRLGLTRIDEAEMTARARRAGLSGHRVRPNIGNNQRRWTFVARRAAASSVRPSR	MAALLKRILRRRMAEKRSGRGRMAAARTTGAQSRKTAQRSGRSEADRRRRVHGQNFLVDRETVQRFVRFADPDPGEVVLEVGAGNGAITRELARLCRRVVAYEIDRHFADRLREATAEDPRIEVVAGDFLKTSQPKVPFSVVGNIPFGNTADIVDWCLNARRLRTTTLVTQLEYARKRTGGYRRWSRLTVATWPEVEWRMGERISRRWFRPVPAVDSAVLRLERRPVPLIPPGLMHDFRDLVETGFTGKGGSLDASLRRRFPARRVAAGFRRARLEQGVVVAYVTPGQWITLFEELHGR	79.93	gnl|BL_ORD_ID|1100|hsp_num:0	1193			231	474	erythromycin; lincomycin; pristinamycin IC; oleandomycin; carbomycin
BGC0000112.1|Neocarzinostatin_15 # 19189 # 20397 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.676	BGC0000112.1|Neocarzinostatin_15 	19189	20397	+	Loose	550	45.4394	PmrF	26.52	3003578	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGACCGCGACCGCCGAAGAGTCCGCCGAACTGACGCGAGTGTCCCTGACCGAGATCGTGATTCCGGTGCGCAACGAGGAGAAGGCGCTCGCACGGAACGTGCACCGGCTGCGTGACTATCTCGTCCGGAACTTCCCGTATCCCTTCGTGATCACCATTGCGGAGAGCGGCAGCGCCGACAGGACACGCGAGATCGGCGAGGAGCTGGCCCGTCAGCTCGCCGAGGTGCGGTTCGTGAGCTTCGATTCGAGGGGCCGGGGCCTGGCGCTCAGGCACGTGTGGGGAACGAGCCGGGCAGACGTGGTCAGCTACATGGACGCCGACCTCTCCATCGACCTGGACGGGTTCCTCCCGCTCATCGCGCCGCTCGCATCGGGCCACAGCGACTTCGCCATCGGCACGCGGCACGCACGCGGGTCGAGCGTGCAGCGGTCACTGCTGCGCGCCACGCTCTCCCGCACGTACAACCTGATCCTGCGCGTAGTGCTGGGAGTGCGCTTCTCCGACGCCCAGTGCGGTTTCAAGGCCGGCCGGCGGGAGGTCGTGCAGGCCATACTGCCGACCGTCCAGGACGACAAGTGGTTCTTCGACACGGAACTGCTCTGTGCGGTGCAGCGCCAAGGGCTGCGCATCCACGAGGTCCCGGTCGACTGCCTTGACGACCCCGACACCACGGTCGCCATCGGCCGTACCGTCGTGGACATGCTCCGGGGTGTGGCCCGTGTGACGGGCCGCCGGATGAGAGGTGCTTTCGGGACGCCCCTGCCGTCACACCTGCAGCGCCTGGGAGTTCCCGTCGCCCCGGCACGCAGATTCTTGCGCTTCGCCATGGTCGGAACGGCAAGCGGACTCCTGCACGTTCTGTTCTACCTGCTGTTCACCACGGTGATGCCCACGTTGGCGGCGAACGCGCTCGGTCTCTTCCTCGCCACCGTCCTCAACACCGCAGCGAACCGCCGAATCACCTTCGGAGTACGAGGGCGCCAGGACGTACTGCGCCATCAGGCCAAGGGTTTCGTCGCCTTCCTGCTCGGTCTGGCCTGCACCAGCACGGCACTGCTCGCGGCCGGTCCGGGAAGCGGCAGGACCGTCGAACTGACGGTTCTGCTCGCCGGAGACGTTCTTGCCTCCCTTGTGAGGTTCGCCCTCCTGCGGCACTGGGTGTTCCGCCCCTCCCGGGGCCGGGACGACAAGGAGGCGGACCGGTGA	MTATAEESAELTRVSLTEIVIPVRNEEKALARNVHRLRDYLVRNFPYPFVITIAESGSADRTREIGEELARQLAEVRFVSFDSRGRGLALRHVWGTSRADVVSYMDADLSIDLDGFLPLIAPLASGHSDFAIGTRHARGSSVQRSLLRATLSRTYNLILRVVLGVRFSDAQCGFKAGRREVVQAILPTVQDDKWFFDTELLCAVQRQGLRIHEVPVDCLDDPDTTVAIGRTVVDMLRGVARVTGRRMRGAFGTPLPSHLQRLGVPVAPARRFLRFAMVGTASGLLHVLFYLLFTTVMPTLAANALGLFLATVLNTAANRRITFGVRGRQDVLRHQAKGFVAFLLGLACTSTALLAAGPGSGRTVELTVLLAGDVLASLVRFALLRHWVFRPSRGRDDKEADR	MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVEASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE	124.84	gnl|BL_ORD_ID|1937|hsp_num:0	2014			6	525	polymyxin B
BGC0000112.1|Neocarzinostatin_17 # 21379 # 21822 # -1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.712	BGC0000112.1|Neocarzinostatin_17 	21379	21822	-	Loose	500	25.7942	mphK	23.21	3004541	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	GTGGTCCCCATTTCCATCATCAGGAATCGAGTAGCGAAGGTCGCCGTCGGCTCGGCGGCGGTGCTGGGGCTCGCCGTAGGGTTCCAGACCCCGGCCGTGGCCGCGGCGCCGACGGCTACGGTGACTCCGTCGTCCGGTCTGTCCGACGGCACCGTGGTCAAGGTCGCCGGCGCGGGTCTCCAGGCCGGAACGGCCTACGACGTCGGGCAGTGCGCGTGGGTGGACACCGGTGTTCTCGCGTGCAACCCGGCGGACTTCTCCTCCGTGACCGCGGACGCCAACGGCTCCGCGAGCACGTCGCTGACGGTGCGCCGCTCCTTCGAGGGCTTCCTCTTCGACGGCACCCGCTGGGGCACCGTGGACTGCACCACCGCGGCCTGCCAGGTCGGCCTCTCGGACGCTGCGGGCAACGGCCCGGAGGGTGTGGCGATCTCCTTCAACTGA	MVPISIIRNRVAKVAVGSAAVLGLAVGFQTPAVAAAPTATVTPSSGLSDGTVVKVAGAGLQAGTAYDVGQCAWVDTGVLACNPADFSSVTADANGSASTSLTVRRSFEGFLFDGTRWGTVDCTTAACQVGLSDAAGNGPEGVAISFN	MTNLNEKQLITEIVGLARSQGLTVHSENAQLNETGMDFQVVFAKDDTGMPWVLRKPRRSDVVERASAEGITLAFLRANLTADVPDWRIHTPELIAYPMLKGTPAAGIDLEQKQYVWNMDHQPPSDDFVRTLADILAELHGTDQISAGQSGIEVIRPEDFRQMTADSMVDVKNKLGVSTTLWERWQKWVDDDAYWPGFSSLIHGDLHPPHILIDQNGRVTGLLDWTEAKVADPAKDFVLYQTIFGEKETARLLEYYDQAGGRIWAKMQEHISEMQAAYPVEIAKLALQTQQEEHINMALEALGVTSD	48.04	gnl|BL_ORD_ID|2624|hsp_num:0	3217			261	582	telithromycin; azithromycin
BGC0000112.1|Neocarzinostatin_18 # 21999 # 22403 # 1 # ID=1_18;partial=00;start_type=TTG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.585	BGC0000112.1|Neocarzinostatin_18 	21999	22403	+	Loose	500	23.483	OXA-513	37.04	3005743	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	TTGCCAACCCCTCCCCTCCCCCGCTTCCGCATCCGGTCACCGCGTCGCATCCATGGTCTGACCAGGCAAAATATGCACCCTGAACGATGGACACCGAAGCACGCTTACCAATTTCCGGTGATGATGCCAGCCACCGCCGGCGTACAACATTCGGATGCACATGGGAGTCCGACCACCTTCTCAACCACCACTTCCGAACAGGTCACACAGGTGCACGACCGACGAAAAGAGCGCACCAGTATACAGTGTGAACTTTCAATCCATATGCCGCATACAAAGCGAGTGATCGCGTGGCAGTGGATATTGCCCCGGCTGTGGCAGCGGCGGGACCCTCCGACCGGTCGACTTCTTTGGTATTGCCGGGCCTCGCCGAAGATCTTGCTGAGCTCCGATGGCCAGTACTAG	MPTPPLPRFRIRSPRRIHGLTRQNMHPERWTPKHAYQFPVMMPATAGVQHSDAHGSPTTFSTTTSEQVTQVHDRRKERTSIQCELSIHMPHTKRVIAWQWILPRLWQRRDPPTGRLLWYCRASPKILLSSDGQY	MTVRRFSCALGAALSLSALAGVPARAAVLCTVVADAADGRIVFQQGTQAACAERYTPASTFKLPIALMGADAGILQGPHAPVWNYQPGYPDWGGDAWRQPTDPARWIKYSVVWYSQLTARALGQERFQRYASAFQYGNEDVSGEPGKHNGLDGAWINSSLRISPLEQLAFLRKLVNRQLPLKPAAYDLAETLFDAGEAGGWRLYGKTGTGSPGSNGVYTPDNAYGWFVGWARKDGRQLVFARLLQDEKATKPNAGLRARDDLMRDWPAMADAPRQ	48.73	gnl|BL_ORD_ID|3778|hsp_num:0	4848			141	222	cloxacillin; oxacillin; cefalotin
BGC0000112.1|Neocarzinostatin_19 # 22390 # 23826 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.685	BGC0000112.1|Neocarzinostatin_19 	22390	23826	+	Loose	400	26.1794	TxR	32.14	3005008	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGCCAGTACTAGCGTGACGGCGAGTCAGAGACCCGATTCTTCGACCGCCCTGGTCGACGCCGGTCGCAGCGCCACGGAAGCCGTCCTGACGGCTGCGGTGCCGATCAGCCGGTCGGCACGTGCCGGTGCCACGGCACGTGCCGTCAGGGCGCAGTCGCTCATCGGTCCATCCCCTCTCCATCACGGCACCGAGGCGTTCCACGCCGCGCTGCCATTGACCGGCGCGGCACTCCTGCCGCGGTCACCACGGCGTTCGACCAGACGAAGGAGCTTCCCCATGCGGCCGTTTCAGGTCCAGATCCCCCAGGCCGACATCGACGACCTCAAGCGCCGGCTGAGCGAGACCCGCTGGCCCGAGCTCGTCGACGTCGGCTGGTCCCGTGGCGCCCCGCTGTCGTACATCAAGGAGCTGGCCGAGTACTGGCGGGACGGCTTCGACTGGCGCGCCGCCGAACGCCGCATCAACCAGTACCCGCAGTTCACCACGGAGATCGACGGGGCCACCATCCACTTCCTGCACGTCCGCTCGCCCGAGCCGGACGCCACGCCGATGGTGATCACGCACGGCTGGCCCGGCACGCCGGTGGAGTTCCTGGACATCATCGGCCCGTTGACCGACCCGCGGGCCCACGGCGGCGACCCCGCCGACGCGTTCCACCTGGTCATCCCCTCGCTGCCGGGCTTCGGCCTGTCCGGTCCGCTCAAGAGCGCCGGATGGGAGCTGGGGCGGATAGCCATGGCCTGGTCCAAGCTGATGGCTAGCCTCGGCTACGAGCGCTACATCGCCCAGGGCGGTGACATCGGCGCCTTCACCTCCCTGCTGCTGGGCGCGATCGACCCCAGCCACCTGGCCGGCATCCACGTCAACCTCCTGCAGACCAACCTGAGCGGGGAACCCGGTGAGCTGGAGACCTTGAGCGATGCGGACAAGGCCCGCCTCGCCGTTTCCGAGCGCTTCCTCGACGACCTGTCCGGTCCCATGAAGATGCAGTCGACCCGGCCGCACACCATCGGCTACATGCTGAATGACTCGCCGGTCGCGCAGCTGGCGTATCTGCTCGAGATGTTCAAGCACTGGGCTCAGACCGAGAACGTCCCCGAGGACGCGGTCGACCGGGACCTGATGCTGACCCACATCTCGCTCTTCTGGTTCACCGCGACCGGCGGTTCCGCGGCACAGGCGCACTACGAGCTGAAGCCGTTCCTTCCGATCACCAGCCTGATCGGCCGGTCCCCGACCCTCGACGTCCCCATGGGCGTCGCGGTCTACCCCGGGGCGCTCTTCCAGCCGGTCCGCAGCCTGGCCGAGCGTGACTTCAAGCAGATCGTGCACTGGGCGGAGCTCGACCGCGGCGGTCACTTCTCGGCCATGGAGGAGCCGGACCTGTTCGTCGACGACCTGCGCACCTTCAACCGGACACTCAAGAAGCTCTGA	MASTSVTASQRPDSSTALVDAGRSATEAVLTAAVPISRSARAGATARAVRAQSLIGPSPLHHGTEAFHAALPLTGAALLPRSPRRSTRRRSFPMRPFQVQIPQADIDDLKRRLSETRWPELVDVGWSRGAPLSYIKELAEYWRDGFDWRAAERRINQYPQFTTEIDGATIHFLHVRSPEPDATPMVITHGWPGTPVEFLDIIGPLTDPRAHGGDPADAFHLVIPSLPGFGLSGPLKSAGWELGRIAMAWSKLMASLGYERYIAQGGDIGAFTSLLLGAIDPSHLAGIHVNLLQTNLSGEPGELETLSDADKARLAVSERFLDDLSGPMKMQSTRPHTIGYMLNDSPVAQLAYLLEMFKHWAQTENVPEDAVDRDLMLTHISLFWFTATGGSAAQAHYELKPFLPITSLIGRSPTLDVPMGVAVYPGALFQPVRSLAERDFKQIVHWAELDRGGHFSAMEEPDLFVDDLRTFNRTLKKL	MKVQKCKATIHRRSLDADPLLPLIGNSTCISELRNKLKKYAQCDAEVLIQGETGVGKGMCARIIHELSSRHIYPFVEVNCGAIPSGLIASELFGHEKGAFTGAISDRIGFIQKANKGTLFLDEIGDMPPDLQIHLLHFLESKQIHKVGADKIIDVDCRVIAASHVDLKSEVIQGGFREDLFYRQNILPLTIPPLRKRGEDTVILSERFLEELSNGKVQSMSPEVKKKLLKHKWPGNVRELRNVIQRAIVMCEDNTLHIADLGLDNNERQLLPSVEQIDLDYLLKAIEDNKHNMSAAARNLGISRTTLYRLIKKYNLPI	150.31	gnl|BL_ORD_ID|4724|hsp_num:0	3753			648	732	tetracycline
BGC0000112.1|Neocarzinostatin_20 # 24324 # 25193 # -1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=8bp;gc_cont=0.671	BGC0000112.1|Neocarzinostatin_20 	24324	25193	-	Loose	600	32.7278	EstT	22.64	3007459	protein homolog model	n/a	n/a	macrolide antibiotic; glycylcycline; tetracycline antibiotic	antibiotic inactivation	macrolide esterase	ATGGTGGAATCAGCAGCAACGGCCGAAGCCGGAGTCGTGGGAGGCGGGTTGCCCCTGGGCGACGACTACGCGGGACCGCGTGACCTCCCGGTCGAGACCGTGGTGTCGGCCGACGGCACCACGATCGCCTACGAGAAGTCGGGAAGCGGCCCGCCCGTCGTCATCATCGGGGGCGGGCTCAACGACAAGGCCATGTTCACACCGCTCGCCCAGAGCCTGTCCCAGCAGTTCACGGTGTTCAACTACGATCGCCGCGGCCGTGGGGGTAGCGGCTACGGGGACCCGGAGCAGTACACGATCGACCGTGAGGTCGAGGACCTGGTCGCCGTGCTCGACGCCATCGGGGAACCGGGCCACGTCTTCGCCAACTGCAGCGGCGGCATGATCGCCATCCATGCCGCGGCGGCCGGCGTCCCCATGGCGAAACTGGGGCTCTACGAACCGCCGTACTCCTCGCCCCCGCTCAACGGTGACGAGGTCGACCGGTTGAAGGCGCTCCTCGCCGAGGACCGCCGCGAAGAGGCGGTGACCCTCTTCGGCAAGGAAATCGTCAAGTTCATGACGGACGAGACGCTGGAGAGGTTCAAGCAGCACCCTGCCTGGCAGGCGTTCGAGTCCATGGCGCCCTCGTGTGTCTACGACGCGATCATCAACGACCGGTACGGTTCCATCCCTCACGCGCTGCTGCCGAAGATCGCTGTCGAGACGCTGGTCCTCAGCGGCTCCGAGAGCGCGCCGTGGATCCAGGAGGCCTGCGTGACGCTCTCCGAGGAGATCCCCCGGGCCCGTCTGCTGCGCATCGAAGGCGAAGGGCACCTGTTCAACCAGCAGACGGGTGCACCGCTGCTGGTGAAGTTCTTCGGGGAGTGA	MVESAATAEAGVVGGGLPLGDDYAGPRDLPVETVVSADGTTIAYEKSGSGPPVVIIGGGLNDKAMFTPLAQSLSQQFTVFNYDRRGRGGSGYGDPEQYTIDREVEDLVAVLDAIGEPGHVFANCSGGMIAIHAAAAGVPMAKLGLYEPPYSSPPLNGDEVDRLKALLAEDRREEAVTLFGKEIVKFMTDETLERFKQHPAWQAFESMAPSCVYDAIINDRYGSIPHALLPKIAVETLVLSGSESAPWIQEACVTLSEEIPRARLLRIEGEGHLFNQQTGAPLLVKFFGE	MKKKLLWILILGLIIISCKQRKTEMKEKIIKTNGIELCTESFGNKKNPAILLVAGATVSMLYWDTEFCQQLSEKGFFVIRYDNRDVGKSTNYEPGSTPYDIVDLTNDAISILDGYKIDKAHFVGISLGGLISQIASIKFADRVNSLTLMSSGPWGDSDPTIPEMDTSILDFHSKAGTVNWTNEDSVVNYLIQGAELMSGKKQFDKQRSEKLIRAEFNRANNYISMFNHAASQGGGGEEYWNRLNEIKQPTLIIHGTDDKIWHYKNAGFLLEKIKGSNLITLEGTGHELHVDDWKSIIDGIEKHIND	94.44	gnl|BL_ORD_ID|4956|hsp_num:0	5948			78	858	tigecycline
BGC0000112.1|Neocarzinostatin_21 # 25294 # 26538 # -1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.664	BGC0000112.1|Neocarzinostatin_21 	25294	26538	-	Loose	500	27.7202	APH(6)-Ia	36.51	3002657	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(6)	ATGACCGAGGCTGTGTGCCCTTACCGTCTTGACCCCGAGGGCGCCGACACCCACGGGGAGACCGCTCGTCTGCGCGAGCAGGGCCCGATCGCACGGGTCGAACTCCAGGACGGCGTGCTTGCGTGGTCGGTGCACGACTACGCGGTCGCCAAGCAGATCATGGCCGACGAGCGCTTCTCCAAGAACCCCCGCAAGAACTGGCCCGCGTACATCAACGGGGAGATATCGAACGGCTGGCCCCTGATCACCTGGGTGGCCATGGACACCATGGCCACCCAGGACGGCGCCGACCACGCACGTCTGCGCAAGCTGCTCCTGAAGGCCTTCACCGAGCGTCGTGTCGAGTCCATGAGGCCGCACATCGAAAAGACGGTGAAGGAACTCCTCGACAACATGGCCGCCAAGGCCGACGACGAGATCGTGGACATCAAGGAGATGTTCCACGCCGAGCTGCCCACGCGGCTGATGTGCGACCTCTTCGGTGTGCCGGAGGAGAGGCGCGCCGAGGTGCTGGCGGGGGGACACAAGAACATCGACACCCGGATCTCCTCCGAGGCGGCGGAAGCCAACCTCGGGCAGTGGCAGGAAGCCATCTCCGATCTCGTCGAGTACAAGCGTCATCACCCCGGTGACGACCTCACGAGTGCACTGATCGAGGCCAGGGACGAGGGTTCGCGGCTGAGTGACTCGGAGCTGATCGGCACGCTGCACCTGCTGCTCGGCGCCGGCTCCGAGACTCTGGTGAATGCCCTCGCCCACTCCTCCCTGGCCCTGCTCGTCGACGCCGACCTGCGCAAGAAGGTGACCTCTGGCGAGATCCCCTGGGTGAACGTCTGGGAGGAGACGCTGCGAGTGGAGTCGCCCGTGGCACACCTGCCCTTCCGCTACGCGACGGAGGACTTCGAGATCGGCGGTGTGAAGATCTCGAAGGGCGATCCCCTGCTGGTCGACTTCGCGGGCATCGGCCGGGACCCTGCCGTACACAGCGATGCCCCCGACGAGTTTGACGCTCTCCGGCCCGACAAGACGCACCTCTCGTTCGGCCACGGCGTCCACTACTGCCTCGGCGCGCGGCTCGCGAAGCACGCCTGGATGATCGGCATCCCCGCATTGTTCGAGCGCTTCCCCGACATGGAACTCGCGGTCCGCCGTGACGAACTCAAGGGGCAGGGAAGCTTCGTGGTCAACGGCCATGCCAGTCTGCCGGTGCACCTGAAGGGCCGGGCCGCGGCTCTCGCCCGGTGA	MTEAVCPYRLDPEGADTHGETARLREQGPIARVELQDGVLAWSVHDYAVAKQIMADERFSKNPRKNWPAYINGEISNGWPLITWVAMDTMATQDGADHARLRKLLLKAFTERRVESMRPHIEKTVKELLDNMAAKADDEIVDIKEMFHAELPTRLMCDLFGVPEERRAEVLAGGHKNIDTRISSEAAEANLGQWQEAISDLVEYKRHHPGDDLTSALIEARDEGSRLSDSELIGTLHLLLGAGSETLVNALAHSSLALLVDADLRKKVTSGEIPWVNVWEETLRVESPVAHLPFRYATEDFEIGGVKISKGDPLLVDFAGIGRDPAVHSDAPDEFDALRPDKTHLSFGHGVHYCLGARLAKHAWMIGIPALFERFPDMELAVRRDELKGQGSFVVNGHASLPVHLKGRAAALAR	MSSSDHIHVPDGLAESYSRSGGEEGRAWIAGLPALVARCVDRWELKRDGGVRSGEASLVVPVLRADGTRAALKLQMPREETTAALIGLRAWGGDGMVRLLDHDEESSTMLLERLDGSRTLASVEDDDEAMGVLAGLLNRLHSVPAPPGLRGLGEIAGAMVEEVPSAVDSLADPEDRSRLRGWASAVAELVGEPGDRVLHWDLHYENVLAAEREPWLAIDPEPLVGDPGFDLWPALDTGWERIEATGDARRVVRRRFDLLTESLELDRGRAAGWTLARLLQNTLWDIEDGLTAIAPSQIAVAEALAKP	134.85	gnl|BL_ORD_ID|1382|hsp_num:0	1500			12	180	streptomycin
BGC0000112.1|Neocarzinostatin_22 # 26841 # 27248 # -1 # ID=1_22;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.630	BGC0000112.1|Neocarzinostatin_22 	26841	27248	-	Loose	200	37.3502	FosK	24.0	3003207	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosfomycin thiol transferase	TTGCTCGGCAGATCTCGGGCTGTGTACGGTGTGAACATGGCAAACGAAAAAGAAAAGACCAATTTTCCCGCCGTGCCTGGCTGGTTCGACATCTCCACCCCTGACTCGTCCCAGACGCGGGCTTTCTACCAGGAAATCTTCGGCTGGACGATCAATGCCCTGGACGACACCTATGCCATGGTGAGCTCCGGGGACGGCCCGCCCTCCGGAGGAATCGGTCAGGCCGGCCCCGAGAGCCCGTATGTCGGGGTCGTTCCCTATTTCCCGGTTGCCGACGTCGAGGCAGCCCTCGCGCAGGCGGAGAAGCTCGGCGGCTCCGTGAAGATGCCGCCGCAGGACACCCCTGCCGGCCGTATCGCCGTCTTCACTGACCCCGACGGCAACAACGTCGGAGTCATGAGTTCCTGA	MLGRSRAVYGVNMANEKEKTNFPAVPGWFDISTPDSSQTRAFYQEIFGWTINALDDTYAMVSSGDGPPSGGIGQAGPESPYVGVVPYFPVADVEAALAQAEKLGGSVKMPPQDTPAGRIAVFTDPDGNNVGVMSS	MITGINHITFSVRDLSSSIEFYRDLLGMRLHVTWEAGAYFTAGDTWVCLSVGEPKPANDYTHVAFSVGERELVELHARLKEAGVEEWKQNTSEGNSVYLLDPNGHRIELHCGTLATRLAELEKSPYKRLVWC	102.27	gnl|BL_ORD_ID|1564|hsp_num:0	1703			27	321	fosfomycin
BGC0000112.1|Neocarzinostatin_23 # 27326 # 28819 # -1 # ID=1_23;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.677	BGC0000112.1|Neocarzinostatin_23 	27326	28819	-	Loose	1000	183.341	efpA	32.77	3003955	protein homolog model	n/a	n/a	rifamycin antibiotic; isoniazid-like antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGACCACGGTGAACCCCGATGTGGCCGCGGACGGCGCCGAGGACCCTCAGGCGAAGGCGGATCCTCGGCGCTGGTGGGTACTGGCCCTGCTCTCCGGCCTGCAGTTCATGATCCTTCTGGACATGACCGTCGTGAACGTGGCGCTGCCGCTTGTCCAGGAGGGTCTCGGCTTCTCGGAGGCAGGCCTGACCTGGGTGGTCAACGGGTATGTGCTGGCGGCCGGAGGCCTGCTGATCCTCGGTGGCCGTCTGGCCGACGTCTTCGGCCGGCGGCGCCTGCTGCTGATCGGCGTCGGCATCTTTGCGGCGTCTTCGGCCGTGTGCGGCGCGGCCGTCGTTCCCGGGATGATGGTCGTGGGCCGGTTCGCCCAGGGAACCGCCGAGGCCATCGCAGCCCCCGCGTCACTCGGATTGATCGCGCTGCTCTTCACCGACCCGAAGGAACGCAACAAGGCCCTCGGTATCTGGGGCGGACTCGTGGCGCTGGGTGGGACCCTGGGATACATCGTCTCCGGAGTGCTGACTGACCTGACGTCCTGGCGCTGGATCTTCTACATCAACCTGCCGGTGGCCCTGGCCGTGCTGCTGGTCATCCCGCGGATGGTCACCGAGAGCCGGATGGAGCGCGAGAGGGACCAGGGGCTCGACATCGCCGGCGCGGTCACCTCGACCGCGGGGCTCGTGGCCATCGTCTACGGACTGCTGCAGGCCGCCGAGCACCCCTGGGAGTCGGCCTCCGTGGTGCTACCGCTCGCCGGTGGCATCGCCCTGCTGCTCGCCATGCTCATCATCGAGCGCCGCGTCGAGAACCCGCTCATCCCGCTGGACTTCTTCGCCAACCGGACCAGGTCGGTCATCAACCTGACCTCCCTGTTCTTCATGGCGGCGTTCATCTCGTACACCTTCATCCTGACGTTGTTCGAGCAGCACGTGCTGAAGTACTCGCCGCTCGAGACCGGCCTGGCGTACCTCCCCCTCGGATTCGGCATCGGTATCGGCATCGGGGTGGGGACCGCGCTGACCCCGCGCATCGGAGTGCGGGCGGTCGTGGCGATGGGCTTCATCGGCGCCGGGATCGGACTGCTGCTGACGAGCACGGTCGATGTCGACACTCGCTATGCCGGAGGGATCCTGCCGGGAATGGTCGTGTTCGGCGTATTCGCGGGCGCCACCATGCCGGCCGCGACGAGCGCCGCCCTCCACCAGGTCACCGACCAGAACTCAAGCCTCGCCTCGGGCGTCCAGAACACCATGCAGCAGATTGGAGGAGCCCTGGGGCTCGCCGTTCTGGTACCTCTGGCCATCCGGTACACCACCAGTGAGATCCAGGCCGGTGTCCCCGTCGAGACCGCAGTGACGTCGGGGTATGTCCTGGCCTTCCGGGTGGGAGCAGCGCTGATGATCATCGGCGGTGTCCTGATCATGGCGCTCTTCGAACGGGTGGACCCGGCACTGCGCGACCCGACCTCCGAGATCGTGGCCCAGACGCGCTGA	MTTVNPDVAADGAEDPQAKADPRRWWVLALLSGLQFMILLDMTVVNVALPLVQEGLGFSEAGLTWVVNGYVLAAGGLLILGGRLADVFGRRRLLLIGVGIFAASSAVCGAAVVPGMMVVGRFAQGTAEAIAAPASLGLIALLFTDPKERNKALGIWGGLVALGGTLGYIVSGVLTDLTSWRWIFYINLPVALAVLLVIPRMVTESRMERERDQGLDIAGAVTSTAGLVAIVYGLLQAAEHPWESASVVLPLAGGIALLLAMLIIERRVENPLIPLDFFANRTRSVINLTSLFFMAAFISYTFILTLFEQHVLKYSPLETGLAYLPLGFGIGIGIGVGTALTPRIGVRAVVAMGFIGAGIGLLLTSTVDVDTRYAGGILPGMVVFGVFAGATMPAATSAALHQVTDQNSSLASGVQNTMQQIGGALGLAVLVPLAIRYTTSEIQAGVPVETAVTSGYVLAFRVGAALMIIGGVLIMALFERVDPALRDPTSEIVAQTR	MTALNDTERAVRNWTAGRPHRPAPMRPPRSEETASERPSRYYPTWLPSRSFIAAVIAIGGMQLLATMDSTVAIVALPKIQNELSLSDAGRSWVITAYVLTFGGLMLLGGRLGDTIGRKRTFIVGVALFTISSVLCAVAWDEATLVIARLSQGVGSAIASPTGLALVATTFPKGPARNAATAVFAAMTAIGSVMGLVVGGALTEVSWRWAFLVNVPIGLVMIYLARTALRETNKERMKLDATGAILATLACTAAVFAFSIGPEKGWMSGITIGSGLVALAAAVAFVIVERTAENPVVPFHLFRDRNRLVTFSAILLAGGVMFSLTVCIGLYVQDILGYSALRAGVGFIPFVIAMGIGLGVSSQLVSRFSPRVLTIGGGYLLFGAMLYGSFFMHRGVPYFPNLVMPIVVGGIGIGMAVVPLTLSAIAGVGFDQIGPVSAIALMLQSLGGPLVLAVIQAVITSRTLYLGGTTGPVKFMNDVQLAALDHAYTYGLLWVAGAAIIVGGMALFIGYTPQQVAHAQEVKEAIDAGEL	93.77	gnl|BL_ORD_ID|2188|hsp_num:0	2427			138	1362	rifampin; isoniazid
BGC0000112.1|Neocarzinostatin_24 # 29160 # 29366 # 1 # ID=1_24;partial=00;start_type=TTG;rbs_motif=AGGA;rbs_spacer=10bp;gc_cont=0.676	BGC0000112.1|Neocarzinostatin_24 	29160	29366	+	Loose	500	21.9422	rmtD2	42.86	3004677	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	TTGGCGCAGAACCGGCCGACGCGTACACTGTCCACATCCACCGTGCCGGAATTCCGGAAGAACCACGGAATCGGGTACGACGCACACATCGGAAGGCACCCGTACGGGACCTGTCCGCGCAGTGCGCGCCACCGACGGGGCCGGACCGCCATCGCCGGAGTCGACTGTTCGACCGCACTGCGGCCGGGAGGCAGGGACACACCATGA	MAQNRPTRTLSTSTVPEFRKNHGIGYDAHIGRHPYGTCPRSARHRRGRTAIAGVDCSTALRPGGRDTP	MSELKEKLLASKKYRDVCPDTIERIWRECSAKFKKEKDADKAAREALHGVTGAFMTEREYKRAMELAATRDWEALLGMHASTRERLPVESMDRVFDQLFEAIGTPARILDLACGLNPVYLAHRLPNAAIAGVDISGQCVNVIRAFGGAEARLGDLLCEIPEDEADAALMFKVLPLLERQRTGAAMEALMRVNAEWIVASFPTRSLGGRNVGMEKHYSEWMEAHVPENRAIAARLTGENELFYVLKRK	27.53	gnl|BL_ORD_ID|2225|hsp_num:0	3376			300	405	amikacin; netilmicin; kanamycin A; tobramycin; gentamicin A; gentamicin
BGC0000112.1|Neocarzinostatin_25 # 29363 # 29980 # 1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.681	BGC0000112.1|Neocarzinostatin_25 	29363	29980	+	Loose	375	33.4982	Escherichia coli AcrAB-TolC with AcrR mutation conferring resistance to ciprofloxacin, tetracycline, and ceftazidime	25.0	3003807	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGATCCGTGACGCGCATCCCTATCACCGCCCGGGCCTGAGGTCCGCGCTCATCGAAGCCGGTCTGAAGCGTGCCCGGAAGGGGGGCGCCGACGCACTCGGGCTCCGGGAGATCACCCGGTCCGTGGGAGTCACGCCGAACGCCGCCTACCGGCATTTCGCAGACCGGCGCGAGCTCGTGCTCGCCGTCGCCGCCCAGGCACAGGACAAACTGGCGCAGGCCATGCTCGACCGCATGCAGGACGTCGTGGACCAGGCGGACCCCGCTGCCCACGCGGTGCAAAAGCTGCGCGGAGTCGGCCTCGGCTACATCCACTTCGCACTGTCCGAACCGGGTTGGTTCGAGCTGGCGATCCTGCTCCAAGAAGAGCCCAGCGGCGAGTCCGAGGCGCGTGTACCACCGCCCTACCAACTCCTGCTCGACGCCCTCGACGGCATGGTCGAGGCAGGCGCGTTGACTCCCGAGAGACGAGTGGACGCCGAGTGGGTCTGCTGGTCGGGGGTCCACGGATTCGCCGATCTGGCGACCCGCGGCCCGTTGCGCCGACAGGACCGTACAGTCGTGGACAAACTCGCCGTCCACGTCGTGAACACCGTCATCAGCGAACTCAAAGCCTGA	MIRDAHPYHRPGLRSALIEAGLKRARKGGADALGLREITRSVGVTPNAAYRHFADRRELVLAVAAQAQDKLAQAMLDRMQDVVDQADPAAHAVQKLRGVGLGYIHFALSEPGWFELAILLQEEPSGESEARVPPPYQLLLDALDGMVEAGALTPERRVDAEWVCWSGVHGFADLATRGPLRRQDRTVVDKLAVHVVNTVISELKA	MARKTKQEAQETRQHILDVALRLFSQQGVSSTSLGEIAKAAGVTRGAIYWHFKDKSDLFSEIWELSESNIGELELEYQAKFPGDPLSVLREILIHVLESTVTEERRRLLMEIIFHKCEFVGEMAVVQQAQRNLCLESYDRIEQTLKHCIEAKMLPADLMTRRAAIIMRGYISGLMENWLFAPQSFDLKKEARDYVAILLEMYLLCPTLRNPATNE	95.35	gnl|BL_ORD_ID|2090|hsp_num:0	2306			36	228	tigecycline; ciprofloxacin; tetracycline; ceftazidime; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000112.1|Neocarzinostatin_26 # 30332 # 31648 # 1 # ID=1_26;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.700	BGC0000112.1|Neocarzinostatin_26 	30332	31648	+	Loose	850	26.9498	baeS	32.43	3000829	protein homolog model	n/a	n/a	aminoglycoside antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACCGGCATCCTCTCCCGGTCCGGGCCCTTCTCCCGTCTGGGCCTGCCGCTCCTCCGCGGGACCCTCAGCACACGCGACAGCGACCTCACCGCTGCGGCACGGGACTTCGGCAACCGCATACACCTCAGGCCCGTGGCCGTGCTGCATCCCGCCGATGCCGAGGACGTCGCGACGATCGTGCGCTTCGGCCGGGAGAACGGGTTCGCGGTGGTCCCCCGGGGTGCGGCCTGCTCGGTGGACGGCCAGGCGCAGACATCGGACGGGATCGTGGTCGATCTCTCCTCGCTCTCCGCCGTCGGTGAGCCGGCCCCCAGCCTCGTACGCGTGGACGGCGGTGCACGATGGCGGGCGGTCCTCGAGGCCACCCTGCCGTGCGGCCGTGTCCCACTCGTGGTACCCGACCATCTCGGCCTGTCCGTCGGCGGGACACTGTCGGTCGGCGGGATCGGCGGCACGAGCCACCGGTACGGCAGCGTCGCCGACAACGTGCTCGAACTCGAGGTCGTCACCGCGAGCGGAGACCTTCTCACCTGCTCGCCCGTCAGACGCCCTGAACTCTTCGATGCTGTAAGGGGGAGCCTGGGCCGGTACGGAATCATCACCGGTGCCACCCTCGCACTCACCGGGGCGAGGAGTTCGGCGCGGACGTACCGACTCGTCTATCACGATTGCGCTGCATTCCTCGCGGACCAGCAACGGCTGGTCCACGAGAGACGGTTCGAGCACGTGGAGGGGCACGCCCACCGCTCCGGAACGTCGGGCTGGCTGTTCGTCCTCGAGGCGATGCAGTCCTTCGACACACCGCACGAGCCCGACGACACCGCGCTGCTCGAGGGCCTCACTCACCATCACGTCGACACGATCGAGACCGTCTCCTACCGCGACTTCCTGGGCCGGGTCGCGCCACTCGAAGCCCGGCAGAGAGCGCTCGGCTCGTGGCAGCACCACCCACACCCGCGGTGCAACGTCCTCCTGCCGGGCCTGGAAGCGGAAGCGCTCATCACAAGGACTCTGGCCGGTCTCACCGAGGAGGACATCGGACCGGGAGGGAGCGTTCTCCTCTATCCCATCCCCACCGCCCGTCTCGCAGCGCCGCATGTTCCAAAGGCGCGCGACGCCCTGACCGTCGTCTTCGGGCTCCAGCGGACGGCACCTCCAGACCAGCCCGAACTGCTGGACCGCATGGTGCGTGACAACCTCGCGCTGCGGGCGGCGGCCAGGAAAGCGGGGGGCGCTGACTACGCGTACGCGGCGACGCACTGCGAAGCCCCGGACGCCTACGAGTCGTTCGGCCGGACCCCGCAGTCCCGCTGA	MTGILSRSGPFSRLGLPLLRGTLSTRDSDLTAAARDFGNRIHLRPVAVLHPADAEDVATIVRFGRENGFAVVPRGAACSVDGQAQTSDGIVVDLSSLSAVGEPAPSLVRVDGGARWRAVLEATLPCGRVPLVVPDHLGLSVGGTLSVGGIGGTSHRYGSVADNVLELEVVTASGDLLTCSPVRRPELFDAVRGSLGRYGIITGATLALTGARSSARTYRLVYHDCAAFLADQQRLVHERRFEHVEGHAHRSGTSGWLFVLEAMQSFDTPHEPDDTALLEGLTHHHVDTIETVSYRDFLGRVAPLEARQRALGSWQHHPHPRCNVLLPGLEAEALITRTLAGLTEEDIGPGGSVLLYPIPTARLAAPHVPKARDALTVVFGLQRTAPPDQPELLDRMVRDNLALRAAARKAGGADYAYAATHCEAPDAYESFGRTPQSR	MKFWRPGITGKLFLAIFATCIVLLISMHWAVRISFERGFIDYIKHGNEQRLQLLSDALGEQYAQHGNWRFLRNNDRFVFQILRSFEHDNSEDKPGPGMPPHGWRTQFWVVDQNNKVLVGPRAPIPPDGTRRPILVNGAEVGAVIASPVERLTRNTDINFDKQQRQTSWLIVALATLLAALATFLLARGLLAPVKRLVDGTHKLAAGDFTTRVTPTSEDELGKLAQDFNQLASTLEKNQQMRRDFMADISHELRTPLAVLRGELEAIQDGVRKFTPETVASLQAEVGTLTKLVDDLHQLSMSDEGALAYQKAPVDLIPLLEVAGGAFRERFASRGLKLQFSLPDSITVFGDRDRLMQLFNNLLENSLRYTDSGGSLQISAGQRDKTVRLTFADSAPGVSDDQLQKLFERFYRTEGSRNRASGGSGLGLAICLNIVEAHNGRIIAAHSPFGGVSITVELPLERDLQREV	93.79	gnl|BL_ORD_ID|913|hsp_num:0	986			1056	1272	novobiocin
BGC0000112.1|Neocarzinostatin_27 # 31855 # 33018 # -1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.677	BGC0000112.1|Neocarzinostatin_27 	31855	33018	-	Loose	400	28.8758	TxR	27.78	3005008	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGAGCCGTTCCGTATAGTGATTCCGCAGGCAGATCTGGACGATCTGCACAGGCGCCTGGATGCCACTCGGTGGCCGAGCGAGATCCCCGGGACGGGCTGGAGCCGCGGCGTCCCGTTGGACTACCTCAAGGAACTGGTCGGTTACTGGCGCGACGGCTACGACTGGCGCGCGGCCGAGGACCGCCTCAACACGGTCCCCCAGTTCACCACCGAGATCGACGGTACGAATGTGCACTTCATGCATATCCGCTCCGCCGAACCCGACGCTCTCCCGATGATCATCACCCATGGCTGGCCGGGTTCGGTCGCCGAGTTCCTCGATGTCATCGATCCCCTGACCAATCCGCGGGCCCACGGGGGCGATCCGGCCGACGCATTCCACTTGGTGATTCCATCCCTGCCCGGATTCGGCTTTTCCGGGCCTACTCCGGAACCCGGCTGGAACCTGCCCCGGGTGGCTTCCGCGTGGGCGGAATTGATGCGACGCCTCGGATACTCCCGGTACGCTGTCCAGGGCGGCGATCTGGGTGCCTGGACCAGCCTGACGCTCTCCGGCGTCGACCACGAGCACGTCGTGGGAACGCATGTGAACTTCCTGATCACTCCTCCCTCGGGTGACCCGGCGGACCTCGCCGGACTCGGTGAACAGGACCTCGCGCGCCTGCAGCTGCTGGCCGAGTTCGGCGCGGAGGGCTCCGGGTACATGAAGATCCAGTCGACGCGACCCCAGACCCTCTCCTACAGCCTGACTGACTCGCCGGTGGGGCAGCTGGCCTGGGTGGTCGAGAAGTTCATGGAATGGGGCGACACGGACAAGTCGCCCGAGGACGCCGTGGACCGTGACCGGCTGCTGACCAACGTCATGATCTACTGGCTCACCGCGACCGCCGGTTCGAGCGCCCACTTCTACTACGAGATCTCCGACGTGCTGCCGACGGCTCCCACGCCGCCCCCTCCTGCGCCACCGCTGCCGACGCCGCTGGGCGTCGCGGTGTACCCGGCCGATTCGGCGAAGCCCGTGCGCCGGTTCGCGGAGCGCGCCTTCCCCAACATCGTGCACTGGGCGGAGCTCGAGCGCGGCGGTCACTTCGCCGCCCTGGAGCAGCCCGGTCTGTTCGTCTCCGACCTGCGGGCGTTCGCCCGCGCGCTGCGGACGTCCTAG	MEPFRIVIPQADLDDLHRRLDATRWPSEIPGTGWSRGVPLDYLKELVGYWRDGYDWRAAEDRLNTVPQFTTEIDGTNVHFMHIRSAEPDALPMIITHGWPGSVAEFLDVIDPLTNPRAHGGDPADAFHLVIPSLPGFGFSGPTPEPGWNLPRVASAWAELMRRLGYSRYAVQGGDLGAWTSLTLSGVDHEHVVGTHVNFLITPPSGDPADLAGLGEQDLARLQLLAEFGAEGSGYMKIQSTRPQTLSYSLTDSPVGQLAWVVEKFMEWGDTDKSPEDAVDRDRLLTNVMIYWLTATAGSSAHFYYEISDVLPTAPTPPPPAPPLPTPLGVAVYPADSAKPVRRFAERAFPNIVHWAELERGGHFAALEQPGLFVSDLRAFARALRTS	MKVQKCKATIHRRSLDADPLLPLIGNSTCISELRNKLKKYAQCDAEVLIQGETGVGKGMCARIIHELSSRHIYPFVEVNCGAIPSGLIASELFGHEKGAFTGAISDRIGFIQKANKGTLFLDEIGDMPPDLQIHLLHFLESKQIHKVGADKIIDVDCRVIAASHVDLKSEVIQGGFREDLFYRQNILPLTIPPLRKRGEDTVILSERFLEELSNGKVQSMSPEVKKKLLKHKWPGNVRELRNVIQRAIVMCEDNTLHIADLGLDNNERQLLPSVEQIDLDYLLKAIEDNKHNMSAAARNLGISRTTLYRLIKKYNLPI	121.70	gnl|BL_ORD_ID|4724|hsp_num:0	3753			585	732	tetracycline
BGC0000112.1|Neocarzinostatin_28 # 33249 # 34574 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.692	BGC0000112.1|Neocarzinostatin_28 	33249	34574	+	Loose	760	31.187	tet(X3)	33.33	3004719	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGAGTGGCTATGTCGGAGATCGTGCCGTGGTCCTGGGAGGCAGCATCGCAGGGTCCCTGGCGGCACGCGTACTCGCCGACGCCTACCGCGAGGTGACCGTGGTCGACCGGGACGACCTCACCGACCGTGCCGAGCCGCGACACGCCACCCCCCAGGGACACCACATCCACGCGCTCCTCGCCCGTGGTCAGCAGATCCTCGATGAGATCTTCCCCGGCTTCACCGACGAACTGGTCGCCCTCGGAGTACCCACCGGTGACTTCGGCACCAGCCTGACCTGGTATTTCAAGGGAATCGCGATCAAGAAGGCAGAGACGGGGCTGACGTGTGTGGCGGCCGGCCGGCCGCTGCTCGAGAACCGAATCCGGCACCGGATCCGGCGCCTGCCCAACGTCACGCTGCGGGAGCAGACGGACGTACTGGGGCTCGTGACATCACCGAACCGCCGCACCGTGACCGGGGTCCGGGTGCAGAGCCGTTCGCACAACTCCGCTGAGGAGGTGCTCGCCGCGGACCTCGTGGTCGACACGACCGGGCGCGGCACGCGGACCCCGCGATGGCTGGCAGAGCTCGGCTATCCGCAAGTCCTTGAGGAACGGGTGAAGATGGACCTGACCTATACGACGTGCCACTTCCGCGGTCCTCTGCCGTTCGACCCGATCGGCGAAGACATCGCCCTTCTGCCAGTCGCCACCCCGGCCATGCGGCGAGGGGCGATCTTCGCCCGGATGCCCGACCGCTACTCACTGTCGCTCACAGGGGTCCTCGGCGACCGGCCCCCCACCGACCACGAGGGATTTCTCTCCTACGCCGAGTCCCTGCCGATTCCAGAGGTGTACAAGGCCCTGCGGGACGCGGAGCCGCTCGGTCCTCCCACGTCGTTCCACTTCCCGGCCAGCATCCGCCGCCGCTACGAACGGCAGGCGCGCCATCTGGGGGGACTGCTCGTGATGGGCGATGCGGCCTGCGTCTTCAACCCGGTGTACGGGCAGGGCATGTCGGTGGCCGCGATCCAGTCGCTCGTACTGCGTGACCACCTGCTCCAGGGGCCGCCCGAGCCGCGCGCCTTCTTCCGTGATCTCGCCGGCGCTATCGACGGGCCCTGGGACATGTCCGCGGGAGCGGACCTCGGTTTTCCGGAGGTTCAGGGGCGGCGAACGGCGAAGACTCGGCTCGGCAACGCCTACGTCACACGCCTTCAGACCGCTGCGGCCGCCGACAGGGAGCTGTCCAAGGCCTTCCTGCGCGCCGCCGGGCTCGTCGACCCGCCCCAGGCGCTCATGCGACCGCGGCTGATCTCTCGCGTCCTGCGCGGCGCTCGGTAG	MSGYVGDRAVVLGGSIAGSLAARVLADAYREVTVVDRDDLTDRAEPRHATPQGHHIHALLARGQQILDEIFPGFTDELVALGVPTGDFGTSLTWYFKGIAIKKAETGLTCVAAGRPLLENRIRHRIRRLPNVTLREQTDVLGLVTSPNRRTVTGVRVQSRSHNSAEEVLAADLVVDTTGRGTRTPRWLAELGYPQVLEERVKMDLTYTTCHFRGPLPFDPIGEDIALLPVATPAMRRGAIFARMPDRYSLSLTGVLGDRPPTDHEGFLSYAESLPIPEVYKALRDAEPLGPPTSFHFPASIRRRYERQARHLGGLLVMGDAACVFNPVYGQGMSVAAIQSLVLRDHLLQGPPEPRAFFRDLAGAIDGPWDMSAGADLGFPEVQGRRTAKTRLGNAYVTRLQTAAAADRELSKAFLRAAGLVDPPQALMRPRLISRVLRGAR	MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKIRSFVTDTQVEETGTFNIQADILQPEINCPGFFQLCNGNRLMAGHQGILLFANPNNNGALYLGISFKTPDEWKNKIPLDFQDRNSVADFLLKRFSKWSEVYKQLIRSVSTFQCLPTRKFPLNNDWKSNRPLPITMIGDAAHLMSPFAGQGVNTGLLDALILSENLTNGEFTSIENAIENYEQQMFVYAKDTQDESTENETEMFSPNFSFQKLLNL	113.66	gnl|BL_ORD_ID|4801|hsp_num:0	3401			915	1023	tigecycline; tetracycline
BGC0000112.1|Neocarzinostatin_30 # 35619 # 37277 # -1 # ID=1_30;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.693	BGC0000112.1|Neocarzinostatin_30 	35619	37277	-	Loose	600	26.9498	FONA-2	39.58	3004789	protein homolog model	n/a	n/a	penam	antibiotic inactivation	FONA beta-lactamase	ATGAGCGGCGGCGCGGAGCGCACGGAGGTCCTGGTCGTCGGCAGCGGGTTCGGCGGCGCGATCAGCGCCTACCACCTCGCAGCCGGGGGCGCGAAGGTGACCGTACTGGAGCGCGGTCCCTGGCTGGAACACGGCCAGTTCGAGCACGACTACAAGCTCGGCTCCTCCTACACGAGGATCTTCGACTTCGTGGTCGGCGACGGGATGAGCGTGCTGGGCGGGAACTGTGTTGGCGGGGGCAGCGTGGTCTACTTCGCCGCCATGCCGCGCGCACCGCGCTTCGTCTTCGACCGGAAGGGCTCCATCGGCCGGCGCATGTGGCCGAAGTCGATCAGTCGCAACACCCTTGACCCTTGGTACGACCGTGTCGAGGAGTCACTGTCGGTCGCCCGGCAGGGCTGGCAGGACGTGAGCTACGCCGGCGGCCTGTGGGCTGCAGCATGCTCCCACGCGGGCCGCACGGCCAACCCTCTCCCGGTGGCCATCGACACCGTCAAGTGTGTCAACTGCAACTGGATGATGGCCGGGTGCCGCTTCGAGGCCAAGCAGTCGCTGCTCGTGAACTACCTCCCCGCAGCCCTCGCCCATGGCGCCGAGATCCGTCCCCTGCACGAGGTCCAGTACCTGGAGCGGACCGCGGACGGCGGGTACCGCGTGCACTACAACGTCATCGACGGCGAGGACTACCGCACGACCGCCGGCAGTGGGGTGATCGAGGCGAAGATCGTCGTGTTGGCGGCCGGTGCCGGGGCGACGCCGGTGATCCTGCAGCGCAGCGAAGGACAGCTCGGCCGGATGCCCCATGCGGTGGGACGCTACTTCTCGGGCAACGGCGAACGGCTCAACACTGCCGTGGTGGACGAAGACAAGGCGGCCGAACTGCTCGGCCTGGACCGCGGGAGCGGGCCAGCGTACGGCGCCAACCACATCGGCCGCGGACCGACCGTCGCGAGTTGGGACCGCCTGGACGGCTCCCTGCCCGAGTACTCCCGTTACTCGCTGGAGCAGCTCTACTTTCCACCCGGCCTGGGCACGATCCTCGCCCAAGTGCCGCACGGCACCGGCCCCACCTGGTTCGGCGCCCGGAAGAAGGAGATCCTCAAACGGTGGACCTCCTGGCTGACGGTCTTCTCGATGATCGAGGACGACAACGAGGGAGTTTTCGGCCCACCGCCAGCGACGGGCAACGCCCACCGTATCTCGCAGCAGTTGCTCGGCCGCGGCAACCTCCGGTACGCGCCCACGCAGAACACGCTCAACGCCTGGGCCGCCTCCGACGCGGAGGTAAAGGAGATCCTTGAGAAGGACGGACTGGCCCAGGTGATGCCTTGGACCAACGACCTGGTCGGCGCATACACCGTGCACCCCCTCGCCTCCTGCCGGATGGGGGACGATCCGCACACGTCCGCTCTCGACGACCGCAACGAGCTGCGGGGGCACCCAGGGATCTTCGTCACGGACGGGTCCGCCGTTCCCGGTGCGCTGACCGTCAACCCGGCCCTGACCATCTCGGCCCTCGCCGAACGGGCCGTGCCGGGCATCGTCGAGGCTGCGCAGGACCGTGGCATCCGCGTCAGCTACGGCGCGCCGGCGCCCAGCGGCTCCGTGAGCGGTCTGCGGCAGGTCCTTCCGCTGCTGCCCCGCCCCGTGGGCACCTGA	MSGGAERTEVLVVGSGFGGAISAYHLAAGGAKVTVLERGPWLEHGQFEHDYKLGSSYTRIFDFVVGDGMSVLGGNCVGGGSVVYFAAMPRAPRFVFDRKGSIGRRMWPKSISRNTLDPWYDRVEESLSVARQGWQDVSYAGGLWAAACSHAGRTANPLPVAIDTVKCVNCNWMMAGCRFEAKQSLLVNYLPAALAHGAEIRPLHEVQYLERTADGGYRVHYNVIDGEDYRTTAGSGVIEAKIVVLAAGAGATPVILQRSEGQLGRMPHAVGRYFSGNGERLNTAVVDEDKAAELLGLDRGSGPAYGANHIGRGPTVASWDRLDGSLPEYSRYSLEQLYFPPGLGTILAQVPHGTGPTWFGARKKEILKRWTSWLTVFSMIEDDNEGVFGPPPATGNAHRISQQLLGRGNLRYAPTQNTLNAWAASDAEVKEILEKDGLAQVMPWTNDLVGAYTVHPLASCRMGDDPHTSALDDRNELRGHPGIFVTDGSAVPGALTVNPALTISALAERAVPGIVEAAQDRGIRVSYGAPAPSGSVSGLRQVLPLLPRPVGT	MVKNTLRKTTLMVATVMPLLFSSAPLWAQTANAKANIQQQLSELEKNSGGRLGVALIDTADNSQILYRGDERFPMCSTSKVMAVSALLKQSETDKNLLAKRMEIKQSDLVNYNPIAEKHLDTGMTLAEFSAATIQYSDNTAMNKILEHLGGPAKVTEFARTIGDKTFRLDRTEPTLNTAIPGDPRDTSSPLAMAKSLQNLTLGKALGEPQRAQLVEWMKGNTTGGASIRAGLPTTWIVGDKTGSGDYGTTNDIAVIWPANHAPLVLVTYFTQPQQNAEARKDVLAAAAKIVTEGL	187.12	gnl|BL_ORD_ID|2034|hsp_num:0	3586			300	444	
BGC0000112.1|Neocarzinostatin_33 # 39249 # 40043 # 1 # ID=1_33;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.670	BGC0000112.1|Neocarzinostatin_33 	39249	40043	+	Loose	230	55.8398	ramA	34.83	3000823	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics	antibiotic efflux; reduced permeability to antibiotic	resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	ATGACTTCCGCTACCATCGAGCACGCAGTTCACCGGGTCATCAGCAATATGCGGGCCAATCTCGGGCAAGACCTGACGATCGACGACATGGCACGCACCGCTATGTTCAGTAAATTCCACTTCACTCGTATATTCAGGGACGTGACCGGCACCTCGCCCGGCAGGTTCCTTTCGGCTCTGCGCATCCAGGAGGCCAAGCGCCTGCTCGTGCAGACGCAGTTCAGCGTCGCGGACATCAGCAGCCTGGTCGGCTACAGCAGCGTCGGCACCTTCAGCTCGCGCTTCAAGGCATGTGTGGGCGTCTCCCCGAGCGTCTACCGCGAACTGGAGGGCTTCGCCACCGGCATCGACCAGGAACCGTGGCCGGACTCCCCCACCTCCCCGGCCGGCGTCTCCGGCATCACTCTGTGGGGCCACGTCACGCTTCCCGAGGGGCGTGCCCCAGGCCCTTGTTACGTCGGCCTGTTTCCCACCCAGGTTCCTCAGGGGCGGCCGGTGAGATGCTCCGTCCTGGAGGGACCCGGCCCCTTCGAACTGCGCAACGTTCCCGTCGGCACCTGGTACCTCCTGGTGCACTCGGTGCCCTACGGCCAGGAGCACCTCGTCTCCGGCGCCGCCGGTGACGAAGACAGCGACACCGTTTCCGTCGGACGCCACGGCCCGCTGACGGTGCGGGCCGAGACAGTGCCCCTGCCGGTCAGTGTCGCGCTGCGACCGCTGGAGGTCTTCGACCCGCCGGTGCTGATGGCACTGCTCGACCTGCGCACCGGCACCCTGGCGAGCGCCACGGGCTGA	MTSATIEHAVHRVISNMRANLGQDLTIDDMARTAMFSKFHFTRIFRDVTGTSPGRFLSALRIQEAKRLLVQTQFSVADISSLVGYSSVGTFSSRFKACVGVSPSVYRELEGFATGIDQEPWPDSPTSPAGVSGITLWGHVTLPEGRAPGPCYVGLFPTQVPQGRPVRCSVLEGPGPFELRNVPVGTWYLLVHSVPYGQEHLVSGAAGDEDSDTVSVGRHGPLTVRAETVPLPVSVALRPLEVFDPPVLMALLDLRTGTLASATG	MINQEAEGESSMTISAQIIDTIVEWIDDNLHQPLRIEEIARHAGYSKWHLQRLFMQYKGESLGRYIRERKLLLAARDLRESDARVYDICLRYGFDSQQTFTRIFTRTFNQPPGAYRKENHSRAH	212.90	gnl|BL_ORD_ID|1537|hsp_num:0	1665			84	351	tigecycline; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000112.1|Neocarzinostatin_34 # 40103 # 41455 # -1 # ID=1_34;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=9bp;gc_cont=0.683	BGC0000112.1|Neocarzinostatin_34 	40103	41455	-	Loose	1500	29.261	rphB	33.33	3003992	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	ATGAATGGGCGGCGTCCGGTCTCCCCTCCGCTGCGGGCGCTACCCGGCCTGTTGCGCAAGCTCGCCGTCGACCGGCTCGGGATGATGCGTGACGCGGCGGCGCTGGACGATGCTGTGCTGGTCTCCATGGGGCCGAAGAAGCTGTTCGTCTTCAACCGGCCCGACTACGCGAAGCACGTGCTGGCGGACAACGCCGCCAACTATCGAAAGGGCATCGGTCTGATCGAGTCCCGGAAGATGCTCGGCGACGGTCTCCTGACGAGCGAGGGTGAACTGTGGCGCGAGCAGCGGCGCACGGTGCAGCCAGCGTTCAGGCCGGCGCGCGTGGCCGCTCAGGCCGACGCGGTGGCGGAAGAGACCATGAACCTTCGGGACCTGCTGATGCGACGGGGCGCCGACGGACCCGTCGACGTACTCCAGGAGGTGACTGGGTTCACGCTCGGTGTGCTGGGCCGGACCGTGCTCAACACCGACCTCGGGGGGTACGGGGGCATCGCCCACGCCTTCGAAGCGGTACAGGACCAGGCGATGTTCGACATGGTCACCCAGAACATGGTGCCGACGTGGGCTCCGCTGGCCACTCAGCGGCGGTTCCGAAGAGCCCGCCGGGAACTCATACGGACCGTTGATGAACTGGTGGCCGACCGCAGCGCTCGCATGACCGACGGAGAGGAGGCCGACGACGCGTTCTCTCTCATGATTGCGGCTGCTCGCCGGCAGACCGATCCGAGGACCGGGCAGGGGCGGCTGCGCGACGAACTGGTGACGCTGCTCCTCGCCGGGCACGAGACTACGGCGAGCACACTGGCGTGGACCTTGCTACTGCTTGCCCGTCATCCGCACATGAGGGATCTGGTGCGCGAGGAGGCCCGCGGAGTGCTTGCGGACGGCCGGGCCCCGGACGCCGGGGACCTGCGCAAACTGACTTACACGACGCAGGTCGTCCAGGAGGCCATGCGTCTGTATCCGCCGGTGTGGATTTTGCCTCGGGTGGCCCGGCAGTCCGACGAGGTGGGACCGTACTCGGTGTCGGCCGGCGCCGACGTCCTGATCTGCCCGTACACCCTGCACCGTCATCCGGATCTGTGGGAGCGGCCGGAACAGTTCGACCCAGGGCGGTTCGACCCGGCGCGCGTCGCCGATCGCCCTCGCTACGCCTACATCCCATTCGGCGCCGGTCCCCGCTTCTGTGTCGGCAGCAACCTGGGGATGATGGAGGCGGTCTTCGTTACCGCCCTCCTGACACGGGATCTCGTCCTGGAGGTCGTGCCCGGCGATGAGAGGACGCCCGAGCCGATGATGTCCCTGCGCATGCGGGGCGGGCTTCCCATGACGGTTCGGCCTGTGCGGTGA	MNGRRPVSPPLRALPGLLRKLAVDRLGMMRDAAALDDAVLVSMGPKKLFVFNRPDYAKHVLADNAANYRKGIGLIESRKMLGDGLLTSEGELWREQRRTVQPAFRPARVAAQADAVAEETMNLRDLLMRRGADGPVDVLQEVTGFTLGVLGRTVLNTDLGGYGGIAHAFEAVQDQAMFDMVTQNMVPTWAPLATQRRFRRARRELIRTVDELVADRSARMTDGEEADDAFSLMIAAARRQTDPRTGQGRLRDELVTLLLAGHETTASTLAWTLLLLARHPHMRDLVREEARGVLADGRAPDAGDLRKLTYTTQVVQEAMRLYPPVWILPRVARQSDEVGPYSVSAGADVLICPYTLHRHPDLWERPEQFDPGRFDPARVADRPRYAYIPFGAGPRFCVGSNLGMMEAVFVTALLTRDLVLEVVPGDERTPEPMMSLRMRGGLPMTVRPVR	MRSLVLDFQEMDKKQLGLVGGKGLHLGELSKIEGIRVPEGFCVTTIGYQRAIEQNETYQAMLNRLTMLSAEDRDQMVEISRKIRQTIMEVEIPSDVVTAVTRYLSRFGEEQAYAVRSSATAEDLPHASFAGQQDTYLNIIGVDAILQHISKCWASLFTDRAVIYRMQNGFDHRQVYLSVVVQRMVFPEASGILFTADPMTSNRKLLSIDAGFGLGEALVSGLVSADGYKVREGEIIEKRIAAKTLAIYGRKEGGTETKQIDPDQQKSQTLTDEQILQLARIGRQIEAHFGQPQDIEWCLAQDTFYIVQSRPITTLYPIPEANDQENHVYVSVGHQQMMTDPMKPLGLSFFLLTTPAPMRTAGGRLFVDTTAMLASPVSRENVLNTLGQSDPLIKDALMTILERGDFIKSLPIAENEQTPGKNNISSAGYQTPIDHDPTIVSDLMERTQSSIEVLKQNIQTKSGSDLFDFILEDIQELKKNLFDPQSSAVIMAAMNASTWINEKMNEWLGEKNAADTLSQSVPGNVTSEMGLALLDVADVIRPYPEIIDYLEQAKDDHFLDKLLTFDGGQQAQDAILDFLDKYGMRCAGEIDLTRTRWSEKPIALVPLILGNIKNFEPNASHRKFEQGRQEALKKEQELLDRLKQLPDGEGKAQETKRMIDLIRNFMGYREYPKYGMVNRYFIYKQALLKEAERLVQAGVIHHKEDIYYLTFEELDEVVRTNKLDNPGSMVEQQAKLAIRQMISKRKEEYNVFEKLTPPRVITSDGEIIAGEYKRENIPAEAIVGLPVSSGTVEGRARVILNMKDADLEEGDILVTAFTDPSWTPLFVSIKGLVTEVGGLMTHGAVIAREYGLPAVVGVENATKRIKDGQRIRVHGSEGYIEILS	50.90	gnl|BL_ORD_ID|2235|hsp_num:0	2528			1833	1947	rifampin; rifaximin; rifabutin; rifapentine
BGC0000112.1|Neocarzinostatin_35 # 41452 # 42000 # -1 # ID=1_35;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.710	BGC0000112.1|Neocarzinostatin_35 	41452	42000	-	Loose	400	26.5646	ErmW	47.06	3001306	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGAGGACACTCGCCGCCGAGTTCTCCCCGCACCCGGGGGAAGCGGCCGATCCGGAGCGGCTGCGTAGCGCGCTGGGGACGTTCGCCACCGGCGTGACCGTGGTGACGGTCGGTGGCTCCTCACCCCACGGCATGACGGCCAATTCCTTCACCTCCGTCTCCCTGGACCCAGCCCTGGTGCTGGTGTGTCTGGGCCGGGACACGGTGATGCACCGTGTCCTGGCCGAGGCCGACACCTTCTCTGTGTCCGTGCTGGACGCCGGGCAGGAGGAGGTGGCCCGACACTTCGCCGACCGCTCCCGGCCGAGGGGCCCGGCCCAGTTCGAGACCGTCGGCTGGGTGCCGGGCCGGTCGGCAGACGCACCACTGATCGCTGGCGCCGCCGCACATTTCGAGTGCGCGAAGTGGCGTGCCTACGAGGGTGGGGACCACACCATATGCGTGGGGAGGGTGCTCACCCTGAGGGAGTCTCCCGACCGGGAGCCGCTGCTGTTCCACCGAGGCCGGTTCCGTCGCTTGCCCGACGGGCGACAGGAGGGTGCGGCATGA	MRTLAAEFSPHPGEAADPERLRSALGTFATGVTVVTVGGSSPHGMTANSFTSVSLDPALVLVCLGRDTVMHRVLAEADTFSVSVLDAGQEEVARHFADRSRPRGPAQFETVGWVPGRSADAPLIAGAAAHFECAKWRAYEGGDHTICVGRVLTLRESPDREPLLFHRGRFRRLPDGRQEGAA	MSSIRRRHAAASLDTPAVGGRHELGQNFLVDRGVCTRIAEVVSSTTAHPVLELGAGDGAITRALVAANLPVTALELDPRRVRRLQRTFADGVTVVHGDMLRYDFGPYPHHVVSTVPFSITTPLLRRLIGQRFWHTAVLLVQWEVARKRAGVGGTTMLTAASWPWYEFTLVERVPKTSFDPVPSVDGGILVIERRSAPLLDDRCVGDYQNLVREVYTGPGRGLAAILRTRLPGREVDAWLRRERVDPAALPRDLKAGHWASLYRLYREVGTRPAPAGRSVRARPGSVGPDRSLPPRGLRSGPPRARRRGGGA	58.52	gnl|BL_ORD_ID|1572|hsp_num:0	1714			183	285	erythromycin; josamycin
BGC0000112.1|Neocarzinostatin_37 # 42448 # 48381 # -1 # ID=1_37;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=13bp;gc_cont=0.707	BGC0000112.1|Neocarzinostatin_37 	42448	48381	-	Loose	500	34.6538	blaC	34.25	3007182	protein homolog model	n/a	n/a	cephalosporin; cephamycin; penam; penem	antibiotic inactivation	class A Mycobacterium tuberculosis bla beta-lactamase	ATGACCAGAATCGCCATCGTCGGCATGGCCTGCCGCTACCCCGACGCCACCAGTCCCGCCGAACTGTGGGCCAACGCCATTGCCGGACGCCGAGCCTTCCGACGCCTCCCCGAGGAACGAATACGTCTGGAGGACTACTGGGACGCCGATCCGTCCACACCCGACACCTTCTACGCCCGCAACGCGGCCGTGCTCGAGGGGTATTCCTTCGACCGCGTTACCCACCGGATCGCCGGCAGTACGTTCAGGTCCACCGACATGACGCACTGGCTCGCCCTGGACACTGCCGGGCGGGCGCTGGCCGACGCCGGGTTCCCGGCGGGTGAGGGGCTGCCTCACGAGCGGACCGGCGTCGTCATGGGCAACACGCTCACCGGTGAATTCACCCGTGCCAACGTCATGCGGCTGCGCTGGCCGTACGTGCGGCGGGTGATGGCGGCCGCGCTCGCCGGACAGCAGGACTGGGACGAGGCCCGGGTCACCGCGTTCCTCGAGGAGGTCGAAACCTCCTACAAGGCGCCGTTCCCGCCCGTCGACGAGGACACTCTGGCCGGTGGGCTCTCCAACACCATCGCCGGCCGGATCTGCAACCACTTCGACCTCAACGGCGGCGGATACACCGTCGACGGAGCCTGCTCCTCCTCGCTGCTGTCGGTCACCACCGCCGGAACAGCTCTGGTCAACGGTGACTTGGACGTCGCCGTCGCCGGTGGTGTCGACCTGTCCATCGACCCGTTCGAGATCATCGGCTTCGCCAAGACCGGTGCTCTGGCCCGGGGGGAGATGAAGCTGTACGACAAGGGCTCCAACGGTTTCTGGCCCGGCGAGGGCTGCGGAGTGGTCGTGCTGATGCGGGAAGAGGACGCGATCGCACGCGGCCACCGCATCTACGCGACCGTCGCAGGCTGGGGGGTGTCCTCGGACGGTCAGGGCGGGATCACCCGGCCCGAGGTCGACGGCTACCGCCTGGCCCTCGAGCGTGCCTACGCGCGTGCCGGGTTCGGCATCGAGACCGTCCCCCTCTTCGAGGGCCACGGCACGGGAACGGCCGTTGGTGACGCGACGGAGCTGGCGGCGCTGATAAAGGCCCGCTCGGCAGCCGACCCGCAGGCGCCTGTCGCCGCCATCGGCTCCATCAAGGGCATGATCGGTCACACCAAGGCGGCAGCAGGCGTGGCAGGTCTGATCAAGGCGGCCCTGGCGGTGGACAACCAGACCCTGCCGCCCTCCATCGGCACCTCCGATCCGCACGAGCTGCTCACCGAGCCAGGGGCCAACCTCAAGGCGCTGCGCAAGGCGGAAACCTGGCCCCGGGAACTGCCGCGCCGCGCGGGCATCACCGCCATGGGGTTCGGCGGCATCAACACGCACGTAGTCCTGGACGAGCCGTCCGGCCGGCGCCGGCCGGCTTCCGTCCGCCGGCTCACCCCCCTGGCCGACTCCATGCAGGACAGCGAACTCCTGCTGTTCGAGGGGGCCTCGGCCCGAGAGCTGAGCCACAGGTTGTCCGAGGTCGCGGACTACACTGTGAGGCTCTCGTACGGGGAGATCGCCGACCTCGCCGCCACTCTCCAGCGCGAGCTCCGGGGCCTTCCGCACCGGGCAGCGGCGGTGGTGACCTCTCCGGACGACGCCGAGAACCGGCTGCGCCACCTCGCGGACCTTCTGGACCGGGGGGAGACGGAGCACTGGGCCGCGGACGGCCGGACCCTCCTTGGAAAGGCCACCGGCCGCAAACGGATCGGTCTGCTGTTTCCCGGCCAGGGCTCTGGACGCGGCACCGGTGGCGGTGCGTTGAGCCGCCGCTTCCCCGAGGTCGCCGAGGTGCTGGCTCGCGCCGGGTCGGCGGCGGGCTCGGACACCGTGGCCACCGAAGTGGCCCAGCCGCGCATCGTCACTGGTTCGGCAGCGGGTCTGCGTGTTCTGGACGAGCTGCGGGTGGAGGCGTCCGTCGGTATCGGACACAGCCTCGGCGAGCTCTCCGCCCTGTGCTGGGCCGGGGCTCTCGACGAGGACGTCCTGATCGAGGCGGCGGGCGTGCGTGGCAGGGCAATGGCGGAGCACGGGTCGTCGGGAACCATGGCGTCACTGGGTGCCGCACCGGAGCAGGCGGAGGAGCTCATCGGCGCCCTCTCCGTGGTCGTGGCCGGCTACAACGGTCCGCAGCAGACGGTCGTCTCGGGTCCCGTGCACGAAGTGGAGGAGGTGCGCAGGCGGGCCGCTCGCTCCGGCGTGACGTGTACGCCGCTTGCCGTGTCCCACGCGTTCCACTCACCGCTCGTGGCGTCCGCCGCCGAGTCGTTCGGCAACTGGCTGAAGAGCGTTGACTTTCGCGAGCCCGCCGGACGTGTGGTGTCCACGGTCACCGGGGCCGAGCTGACACCGGGCACTGACCTGTCGGCGCTGCTGCGGGAGCAGATCACCGCTGCGGTGCGTTTCACCGAAGCGGTCAGGGCCGCGGCCCAGGACGTCGACCTGTTCATCGAGGTGGGACCCGGCCGGGTGCTCGGCCACCTGGCCGGGACGGCGACGAACATTCCCGCGGTTTCCCTCGACACGGACGACGAGTCCCTGCGATCGCTCCTGCAGGTGGTGGGCGCCGCGTTCGTCGTCGGCGCGCCCGTCGCCCCCGAACGCCTCTTCCGGGACCGGTTGATACGCCCGCTCCGGATTGGCCAGGAGCTCTCCTTCCTGGCCAGTCCATGCGAACAGGCACCGGCGACGACCCTACCCGTATCGCGCCGGTCCGCCCAGCCGCCCGCCGTACCTGCTGATCGCGAACAAGAGCCGCAGCCCGCGGCCGTGTCACCTCCGGCAGCACAGAACTCCCCGGCCTCGAACGACACCTCCACCGCGTCCACCGCGTCCACCGCCGGGTCCGAGCGGACGCCTCAGGAGGAGGAGAGCATCGGCGCCAAGGCCCTCGATGTCCTCAGTGCCCTGGTCGTCGAGCGAGCCGAACTCCCGGCCCACCTGGTGGACCCGGACAGCAGGCTCCTGGACGACCTGCACCTGAGCTCCATCACCGTCGGCCAGATCGTGAACCAGGCCATGGCGCAACTCGGTATCGCCCCGGCAGCGCAGGAGCCGACGAACTTCGCCACTGCCACGCTGGCGGAACTGGCCGAAGCGCTCGAGAGCCTGGCCAGTACCGGCGGCCCGGCCGATGCCGGTGCGGCTTCGTTCATCGCCGGAGCGGCGCCGTGGGCGCGTCCCTTCGCGGTGGACCTGGACGCGGTCGCCCGGCCGCCGGCGCGTCCGGCAGCGGTTCGCGGCACCTGGGAGCTGTTCGCACCGGCCGGGTATGGGATCGCCGCGACACTGCGCGCGGCGCTCCAGGACGCCCAGGCGGGTTCCGGAGTGCTGGTCTGTCTGCCGCCCCAGTGCTCTGCCGACGGGATCGACCTGGCGCTAGCAGCGGCGAAGCGGGCGCTCGCCGCCCCGAAGGACAGCCGTTTCGTGCTGGTGCAGCACGGCCGCGCTGCCGCCGGCCTGGTCAAGACCCTCCACCAGGAGGCGTCCCACCTGGTGACGACTGTCGTCGACACCCCCCTCACCGAGGACACGGTGGACCGGGTGGTCGCCGAGGTGTCGGCGACCACCCGGTTCTCCGAGGTGCACTACAGCGCGGACGGAGTCCGCCGCGTCCCCACGCTGCGGGCACTCCCCATGAGCCCGGAGCAACAGGACAAACCGCTCAGCGCATCCGACGTCCTGCTGGTCACCGGGGGTGGCAAGGGCATCTCCGCCGAGTGCGCCCTGGCGATCGCCCAGGACAGCGGGACACGGCTTGCGGTGCTGGGACGCTCCGACCCGGCCACGGACCGAGAACTGGCCGACAACCTGAAGCGGATGGAGGACAGCGGTGTAACCATGCGGTACGCGCGCGCCGACGTCACCAATCCGGAGCAGGTCCGGACGGCAGTCGCCGAGCTGCGCGGCGAGCTGGGTCCGATCACCGGCGTGCTGCACGGCGCCGGACGTAACGAACCCGGGCCGTTGCATGCGTTGGAACCGGAGGACTTCCGGCGTACCTTCGCTCCCAAGGTGGACGGCCTACGGACCGTACTCGAGGCAGTGGACGCCGAGGAACTGAAACTGCTCGTCACGTTCGGCAGCATCATCGGCCGTGCCGGCCTGCGGGGCGAGGCGCACTACGCCACCGCGAACGAGTGGCTGGCCGACCTCACCGAGGAGATCGCACGCACGCACCCGCAGGTACGCGCCCGCTGCGTGGAATGGTCGGTGTGGTCCGGGGTCGGGATGGGTGAGAAGCTCTCGGTCGTCGAGTCGCTCTCCCGCCAAGGCATCGTCCCGGTCTCCCCGGATCAGGGGGTAGAGATCCTCCTGCGGCTGATCCGGGATCCCGACGCGCCGGTGGTGACGGTCGTCAGCGGCCGTACCGAAGGCATCGAGACGGTGCGCCGTGACCTGCCGCCCCTGCCGCTTCTCCGGTTCACCGGCACCCCGCTGGTGCGCTACCACGGCGTGGAGCTCGTCACCGAGGTCGAGCTGAACGCGGGCACGGACCCCTACCTCGGCGACCACCTGCTGGACGGCAATCTCCTGCTGCCTGCGGTGATGGGGATGGAAGCCATGGTTCAGGTCGCGGCCGCGGCCACCGGCTGGCCGGGGACACCGGTCATCGAGGGCGCGCGCTTCCTGCGTCCCATCGTGGTTCCACCCGACGGGAGCACCACCATCCGTGTCGCCGCGACGGTGACCGGACCGGACACGGTCGACGTCGCCGTCCACGCCAGCGACACCGGATTCGCCGCAGAGCACTTCCGCGCCCGGCTGGTGTATTCCGTCGCCGGTGTCCCGGACGGGCCGCCGCTGCAGACGGGCTCCGACACCCCGGAAGTTCCTCTGGACCCAGCAAGCGACCTCTACGGCGGCATCCTCTTCCAGGGCTCCCGCTTCCAGCGGTTGCGGCGATTCCACCGAATGGCGGCCCGGCACGTGGACGCCGACGTGACAGTGCGAAGGCCGGAGGGCTGGTTCGCCGGCTTCCTCCCTGCGGAGATGCTTCTGGCCGACCCCGGCATGCGCGACGCGCTGATGCACGGCAACCAAGTGTGCGTGCCCGACGCCACGCTGCTTCCTTCGGGGGTCGAGCGTGTCCACCCCCTGGGCAACAGCGGGAATGTACCCGACCAACTGCGTTACTGCGCGGTCGAGCGCAGCCGTGACGGCGACACATACGTGTACGACATCGCGGTACGCGACGCCGAGGGCACCGTCGTCGAACGCTGGGAAGGTCTGACCCTGCACGCGGTGCGCAAGACCAACGGCTCCGGCCCCTGGGTCGCGCCCCTGTTGGGACCGTACCTGGAGCGGACCCTCGAGGAAGTGCTCGGTGCGCACATCGCGGTGACGGTCGAACCGCACGGCGACAACCCGGCTGGGTCGGTCGCCGAACGTCGGGCCCTGACCACCATCGCGGCCTCCCGGACCCTCGGGGCCGCCGTGACCGTGCGTCACCGGCCCGACGGGCGGCCGGAGGTGGATGGTGGGTGGCACATCTCGGCCTCCCACGGCCTGGAACTCACCGTGAGCGCTGTGGCCCGGGCGGAGGTTGCCTGTGACATAGAGGCGGTCAGCATGCGGGAGCCGAGCGAGTGGCAGGGGCTGCTCGGCGAGTACGCCGCGGTCGCCGAACTCGTCGCCCGGGAGACCGGCGAAGCTCCCGACACGGCCGCCACCCGGGTGTGGAGCGCGGTCGAGTGCCTGAGGAAGGCGGGCGCCATGGCGGGCACACCGCTGACCGTACTGCCGCAGAAGAAGGAAGCGTGGGTGGTCTTCACCGCCGGCGACCTCCGGATCGCGACCTTCGTCACGGCCCTGCGGGACGCTCTGGAACCCGCCGTCTTCGCATTCTTGACGCGCACACCGGAACTGCTGGAAGGACGGTCCCAGGACTATGTCGGATGA	MTRIAIVGMACRYPDATSPAELWANAIAGRRAFRRLPEERIRLEDYWDADPSTPDTFYARNAAVLEGYSFDRVTHRIAGSTFRSTDMTHWLALDTAGRALADAGFPAGEGLPHERTGVVMGNTLTGEFTRANVMRLRWPYVRRVMAAALAGQQDWDEARVTAFLEEVETSYKAPFPPVDEDTLAGGLSNTIAGRICNHFDLNGGGYTVDGACSSSLLSVTTAGTALVNGDLDVAVAGGVDLSIDPFEIIGFAKTGALARGEMKLYDKGSNGFWPGEGCGVVVLMREEDAIARGHRIYATVAGWGVSSDGQGGITRPEVDGYRLALERAYARAGFGIETVPLFEGHGTGTAVGDATELAALIKARSAADPQAPVAAIGSIKGMIGHTKAAAGVAGLIKAALAVDNQTLPPSIGTSDPHELLTEPGANLKALRKAETWPRELPRRAGITAMGFGGINTHVVLDEPSGRRRPASVRRLTPLADSMQDSELLLFEGASARELSHRLSEVADYTVRLSYGEIADLAATLQRELRGLPHRAAAVVTSPDDAENRLRHLADLLDRGETEHWAADGRTLLGKATGRKRIGLLFPGQGSGRGTGGGALSRRFPEVAEVLARAGSAAGSDTVATEVAQPRIVTGSAAGLRVLDELRVEASVGIGHSLGELSALCWAGALDEDVLIEAAGVRGRAMAEHGSSGTMASLGAAPEQAEELIGALSVVVAGYNGPQQTVVSGPVHEVEEVRRRAARSGVTCTPLAVSHAFHSPLVASAAESFGNWLKSVDFREPAGRVVSTVTGAELTPGTDLSALLREQITAAVRFTEAVRAAAQDVDLFIEVGPGRVLGHLAGTATNIPAVSLDTDDESLRSLLQVVGAAFVVGAPVAPERLFRDRLIRPLRIGQELSFLASPCEQAPATTLPVSRRSAQPPAVPADREQEPQPAAVSPPAAQNSPASNDTSTASTASTAGSERTPQEEESIGAKALDVLSALVVERAELPAHLVDPDSRLLDDLHLSSITVGQIVNQAMAQLGIAPAAQEPTNFATATLAELAEALESLASTGGPADAGAASFIAGAAPWARPFAVDLDAVARPPARPAAVRGTWELFAPAGYGIAATLRAALQDAQAGSGVLVCLPPQCSADGIDLALAAAKRALAAPKDSRFVLVQHGRAAAGLVKTLHQEASHLVTTVVDTPLTEDTVDRVVAEVSATTRFSEVHYSADGVRRVPTLRALPMSPEQQDKPLSASDVLLVTGGGKGISAECALAIAQDSGTRLAVLGRSDPATDRELADNLKRMEDSGVTMRYARADVTNPEQVRTAVAELRGELGPITGVLHGAGRNEPGPLHALEPEDFRRTFAPKVDGLRTVLEAVDAEELKLLVTFGSIIGRAGLRGEAHYATANEWLADLTEEIARTHPQVRARCVEWSVWSGVGMGEKLSVVESLSRQGIVPVSPDQGVEILLRLIRDPDAPVVTVVSGRTEGIETVRRDLPPLPLLRFTGTPLVRYHGVELVTEVELNAGTDPYLGDHLLDGNLLLPAVMGMEAMVQVAAAATGWPGTPVIEGARFLRPIVVPPDGSTTIRVAATVTGPDTVDVAVHASDTGFAAEHFRARLVYSVAGVPDGPPLQTGSDTPEVPLDPASDLYGGILFQGSRFQRLRRFHRMAARHVDADVTVRRPEGWFAGFLPAEMLLADPGMRDALMHGNQVCVPDATLLPSGVERVHPLGNSGNVPDQLRYCAVERSRDGDTYVYDIAVRDAEGTVVERWEGLTLHAVRKTNGSGPWVAPLLGPYLERTLEEVLGAHIAVTVEPHGDNPAGSVAERRALTTIAASRTLGAAVTVRHRPDGRPEVDGGWHISASHGLELTVSAVARAEVACDIEAVSMREPSEWQGLLGEYAAVAELVARETGEAPDTAATRVWSAVECLRKAGAMAGTPLTVLPQKKEAWVVFTAGDLRIATFVTALRDALEPAVFAFLTRTPELLEGRSQDYVG	MRNRGFGRRELLVAMAMLVSVTGCARHASGARPASTTLPAGADLADRFAELERRYDARLGVYVPATGTTAAIEYRADERFAFCSTFKAPLVAAVLHQNPLTHLDKLITYTSDDIRSISPVAQQHVQTGMTIGQLCDAAIRYSDGTAANLLLADLGGPGGGTAAFTGYLRSLGDTVSRLDAEEPELNRDPPGDERDTTTPHAIALVLQQLVLGNALPPDKRALLTDWMARNTTGAKRIRAGFPADWKVIDKTGTGDYGRANDIAVVWSPTGVPYVVAVMSDRAGGGYDAEPREALLAEAATCVAGVLA	643.97	gnl|BL_ORD_ID|4814|hsp_num:0	5800			666	861	cefoxitin; amoxicillin; cefalotin; temocillin; ticarcillin
BGC0000112.1|Neocarzinostatin_38 # 48378 # 49466 # -1 # ID=1_38;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=9bp;gc_cont=0.678	BGC0000112.1|Neocarzinostatin_38 	48378	49466	-	Loose	550	27.7202	CDD-2	32.43	3006905	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CDD beta-lactamase	ATGTCCGCAGCACAGCCCCTGTCCCAGACCGCGGGACCGCGCCACAACCCGAAGGTCGTCACCGCCCTCCGCCGCTTCGCGATCTCGATCTCCGTACTCAACATCGTCGGCTACACCGTACTGGGCTTCGAACAGCCCTGGCTCTGGCCCTTCATCGCGCTGGCGACGGCCTACACCGTGGAGCTCACGCTCGAGGCCGTCGGTGCACGCGCCGAGAAGCGAGCGACTCGCTTCCGCGGGGGCGGCTTCCGAGGGCTGATGGAATTCCTCTACCCCGCACACATCACGGCCCTCGCGGTGAACATGCTCACCTACGTCAACGACCAGGTGTGGGTCATGGTGTTCGGCGTCGTGGTGGCGGTAGGCGCCAAGTGGGTGCTGCGGGCCCCGGTGAGGGGCCGCATGCGCCACTTCATGAACCCCTCGAATCTCGGCATCGCGGTCATCCTGCTGTTGTTCCCGTGGGCGTCGATCGCCCCGCCGTACCACTTCACCGAGTACGTGGACGGCGGCATTGACTGGCTCGTGCCGGCCGTCATCCTCACGCTCGGCACCATGCTCAACGCGAAGCTCACCGAACGCATGTGGCTCATCGTCGCGTGGGTCGGCGGGTTCGCCGCGCAGGCGGTCGTGCGAGGGCTGTTGTTCGGCACGTCGATTCCTGCGGCCCTCGCGATGATGACCGGTGTGGCGTTCGTACTCTTCACGAACTACATGATCACGGACCCCGGCACCACGCCGTCCTCCAAGTGGGGCCAGATCGCCTTCGGGGGCGGTGTCGCCGCCGCGTACGGCCTCCTGACGGCGCTGAGTGTCGCCTACGGGATCTTCTTCGCCACCGCTCTGGTCTGCGGGGTCCGCGGTGGCTTCCTGTGGATCAGCGACATCGTCTCCCGCAGGCGCACCGAGGAGGCCCTGGCCGTTGCCGCGGTCGGCCTGACCTCCGAGAAGCCCTCCGTCGAGCGCACCCCGATCGAGCACGCGGAAACACTCCCGTGCGTGAACGGCTGCGCCGAAGGGGCCTGCTCCTGCTCCGGGAACCCGAAGGACAGCGAGGCGGACGACCGCAGGATCGTGGTGTCGGCATGA	MSAAQPLSQTAGPRHNPKVVTALRRFAISISVLNIVGYTVLGFEQPWLWPFIALATAYTVELTLEAVGARAEKRATRFRGGGFRGLMEFLYPAHITALAVNMLTYVNDQVWVMVFGVVVAVGAKWVLRAPVRGRMRHFMNPSNLGIAVILLLFPWASIAPPYHFTEYVDGGIDWLVPAVILTLGTMLNAKLTERMWLIVAWVGGFAAQAVVRGLLFGTSIPAALAMMTGVAFVLFTNYMITDPGTTPSSKWGQIAFGGGVAAAYGLLTALSVAYGIFFATALVCGVRGGFLWISDIVSRRRTEEALAVAAVGLTSEKPSVERTPIEHAETLPCVNGCAEGACSCSGNPKDSEADDRRIVVSA	MKRKNNFIWIVILLVVVAMGVYYVGRKHNNTKQKHDKNHINSELNKSKVENKKEKINMVDYSDCFEGISGGAIFYNTKNKEYNIYNKELIETRRSPCSTFKIVSTLIGLEKGVINSKESVMGYDGTEYPNKNWNKNLSLEEAFKESCVWYYKKLIDKVDAKSVQNILDDLKYGNCDISEWEGDLKNGKGHLNGFWLESSLQISPKEQVQTMAKIFEGDTNFKKEHINILRDIMKIDVNDKNINVYGKTGTGFDEKNKRVDAWFVGMLEREGDTYYFAIKSDDSNKEITGPKVKEIAINIIKKYYSVRE	117.53	gnl|BL_ORD_ID|3372|hsp_num:0	4441			12	123	
BGC0000112.1|Neocarzinostatin_39 # 49469 # 51373 # -1 # ID=1_39;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=15bp;gc_cont=0.654	BGC0000112.1|Neocarzinostatin_39 	49469	51373	-	Loose	950	28.1054	fusH	50.0	3003026	protein homolog model	n/a	n/a	fusidane antibiotic	antibiotic inactivation	fusidic acid inactivation enzyme	ATGGCGAAGAACTGGCTACGCAGGAATTCTCCGGGAATCGTCGCGCTCACCCTGATGGCGAGCGTCTTCTACGTCGTTCGCCTCCCTGAACCGTCTGCCGCCGATGTCAGGGAATCGGCAGCCGACTTCGCCTTCGAGCCGATGACCATAGCCATGCCGGGAGGATTTCCCACACAGAAGATCAGACAGGTCAACAAGGCTTACGAGCACATCGACGCCTGGATTTCATCGGTCGGCGCCGGCATCGCCCTCAATGACATGGACGGCGACGGCCTGTCCAATGATCTGTGCCTGACCGACCCCAGGATCGACCAGGCCGTGGTGACCCCGGCTCCCTCGCGCGGCAAGGCCTACGAACCGTTCGCACTCGATGCGGCCCCCCTGGGAATCAGCGACACCATGGCTCCGATGGGGTGCGTACCCGGTGACTTCAACGAGGACGGCGCCATCGACCTGCTCGTCTACTACTGGGGCCGCACCCCTGTGATCTTCCAGAACGAAGGTGGCCGTGGCGAGCCACTCACCGCTTCCTCGTTCACGCCCACGGAACTGCTACCGGGTAAACCCGGCCCGCGGTACACGGGTCCGCTGTGGAACAGCAACACAGCCGCCGTCGCCGACTTCGACGGCGACGGACACGACGACATCTACATCGGCAACTACTTCCCCGACAGCCCGGTCCTCGACCCGTCCAAGAACGGCGACGTCACCATGAACGACTCGCTGTCGCACGCCCAGAACGGCGGTGGTGGTCACTTCTTCCGCTGGACCGAGTCCGGTTTCGAGAAGACGGACGATGCCATACCGCAGGGCCTCAACAAGGGATGGTCACTCGGCGCGTCGGCCGCGGACCTTGACGGCGACCGTCTTCCTGAGATCTTCCTCGCCCATGACTTCGGGACCTCGGCGCTGTTGCACAACACCTCGCGGCCGGGCCGGATCGAGTTCCGCGAGGTCAAAGCGGTCCACTCCGGCACCGTTCCCAAGTCCAAGGAGATCGGACGCAGCTCCTTCAAGGGGATGGGTGTCGACTTCGGTGACCTGGACCACGACGGCCTGTACGACATGTTCGTCAGCAACATCACGACATCGTTCGGGATCCAGGAGTCGAACTTCGCCTTCATCAACAAGGCCGGCGACAAGGCCGACCTGCGGTCCCGCTTCGAGAACGGCGAGGCGCCCTACAGGGACGAGTCGACCGACCTCGGCCTGGCCTGGTCCGGCTGGGGCTGGGACGTGAAGATGGGCGATTTCGACAACAACGGCGATCTTGAGATCACCCAGGCGCTCGGTTTCGTCAAGGGCAAGAACAACCGCTGGCCGCAGTTGCAGGAACTCGCCACGTCCAACGACGCGCTGGTCGCCAACCCCACCTGGTGGCCGAACGTCAGGCAGGGAGATGACCTCGCCGGCAGCCAGCGGATGCGGTTCTTCGCCAAGGACCAGGACACCGGCCGCTACATCAACCTCTCCACGGCGCTGGGCCTGGGGGATCCTGTTCCGACCCGTGGCATCGCGACCGGTGACGTGGACGGCGACGGCCGCCTCGACATCGCAGTCGCCCGCCAGTGGGACGAGCCCGTCTTCTACCGCAACACGGCCCCCGAGCCCGGCTCCTGGCTGGAACTCGTCTTCACGCACCCCGACGGTGCTCCGGTGGTCGGAGCCGAAGTCCGCGTCGAGCTGCCCGACGGGAGCAAGAGGGTCGCCCGCGTCGACGGGGGCGGTGGCCACTCGGGCAAACGAAGTACCGATATCCACATCGGCCTGGGCGAGGAGGCCCAGGGCGAGGTCTCAGGGACGGTCACCTGGCGCGACCGCGAAGGTGACGTCCACGAGCAGGAAGTGAGGCTGGCGCCGGGCAGGCACAGCTTCGAGCTCGGCAGCCAGGTCAAGGAGAAGTGA	MAKNWLRRNSPGIVALTLMASVFYVVRLPEPSAADVRESAADFAFEPMTIAMPGGFPTQKIRQVNKAYEHIDAWISSVGAGIALNDMDGDGLSNDLCLTDPRIDQAVVTPAPSRGKAYEPFALDAAPLGISDTMAPMGCVPGDFNEDGAIDLLVYYWGRTPVIFQNEGGRGEPLTASSFTPTELLPGKPGPRYTGPLWNSNTAAVADFDGDGHDDIYIGNYFPDSPVLDPSKNGDVTMNDSLSHAQNGGGGHFFRWTESGFEKTDDAIPQGLNKGWSLGASAADLDGDRLPEIFLAHDFGTSALLHNTSRPGRIEFREVKAVHSGTVPKSKEIGRSSFKGMGVDFGDLDHDGLYDMFVSNITTSFGIQESNFAFINKAGDKADLRSRFENGEAPYRDESTDLGLAWSGWGWDVKMGDFDNNGDLEITQALGFVKGKNNRWPQLQELATSNDALVANPTWWPNVRQGDDLAGSQRMRFFAKDQDTGRYINLSTALGLGDPVPTRGIATGDVDGDGRLDIAVARQWDEPVFYRNTAPEPGSWLELVFTHPDGAPVVGAEVRVELPDGSKRVARVDGGGGHSGKRSTDIHIGLGEEAQGEVSGTVTWRDREGDVHEQEVRLAPGRHSFELGSQVKEK	MLNKGIRTRRARGALAGGTVLTAAAALLTAVPAAQAISGEPPAATDHAFTARLHIGEGDTLRGCSAALVHQQWLLTATSCFAATPGGEVKSGKPALKSTATLGGKTLGIVEVVPRDDRDVAMVRLAEPVTTVEPVRLAADAPVAAETLLGAGFGRTRTEWAPDQLHTGEFRVDSVTGTTVELTGQDGVSVCKGDTGGPALRGTGGEVELAAVHSRSWQGGCFGETETRTGAVDARADGLADWVTDVRNRDRTQSADVDGDGRADLVVLRSNGDVVVHRNLGDSFAAGRVMSGGWGLFVTWKDLGRLYFADVDGDRKADMIVHTSDGNIEVRFNHGTYWDQGTHWSGGWGRFIDGSDLGRLYFADVDGDGRADMIVHTGDGNVEVRFNHGTYWDQGTHWSGGWGRFVTWKDLGRLYFADVDGDGRADMIVHTGDGNVEVRFNHGTYWDQGTHWSGGWGRFVDGSDLGSLEFGDATGDGKADLLVRTKDGKVALRTNHGTYWDQGKFMITL	124.56	gnl|BL_ORD_ID|65|hsp_num:0	75			759	837	fusidic acid
BGC0000112.1|Neocarzinostatin_41 # 52446 # 53426 # -1 # ID=1_41;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=14bp;gc_cont=0.699	BGC0000112.1|Neocarzinostatin_41 	52446	53426	-	Loose	750	27.7202	tet(E)	30.77	3000173	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTCCATCATGGGAGCGTTTCGCAGAGCGGTCATGGCGCCCTCTCTGACCGAAGTGGGTTTCGCCGGCCGGGGTTTTGCCGTCATCTCCACCGAGGAGACCAGGCGTCTGGAAGGCGTCCCGCAGGCTGTCGTCTGTGGTTTCGAATGGGCCATTGGGGACCGCTCGCTGGCGGACACGGAGCGCCGCCTGTCCATGGTCGACGCGGACGTCCGGGGCTTCGCCTACGAAGGGGCGACGATGGCGTGCGCGGTCAGGGACGCGATGGGCACCCGGCGGGGCCAACGCACCCGGGACCTCCTGCAGGGTGACGGAGGCAGACCCCACATCTTCCTGAACTACATCGGCATCGGATTTGCCATGGCACGCCTCCCCCGGCCTCTGTGGCGTGGAATCCTGCCCCCGCTCACGGGCGCCGAGTACTACCCCGCGATGAACTGGCTGGCCGTGGACGGCTACGGATTCGACCGTGCCTACTTCGACACGGCACGCTGGGTCGACCGGCAACGACGTCCACGGCCATATGCCTGGCAGGGGGACGCCGACTACTTCCTCCGCGCCGTCGACCAGGGCATCGGGCGAGCCCTGTGGTTCATCCACGGGGCCCACGTCGACCATGTCACCGCTGCCGTTTCCGCATTCGCCGAACGGCGCCACGCGGACCTATGGAGTGGTGTGGGCCTGGCCGCCACCTTCGCCGGCGGCGCTCCTGCCCTGATGACGGCACTGCGCCGGAACGCCGGCGCGCACGGTGGGCATCTGGCCCAGGGAGCGGTCTTCGCCGCCAAGGCGCGCCACCACTGTGGGCATGTTCCCGAGCACACGCGGGCCGCCGTACAGGCCCTCACCGGCCTCGAGGTCCGGGCGGCCGCCGAACTCGCCGACGACTGTGCCGTCCCCGCGTCCGAGAGCGGGGTCGTACCGACCTACGAGATCTGGCGGCGCCGAGTGCGCGAGCGGGTCTCCGCCGTCTCCGTCTGA	MSIMGAFRRAVMAPSLTEVGFAGRGFAVISTEETRRLEGVPQAVVCGFEWAIGDRSLADTERRLSMVDADVRGFAYEGATMACAVRDAMGTRRGQRTRDLLQGDGGRPHIFLNYIGIGFAMARLPRPLWRGILPPLTGAEYYPAMNWLAVDGYGFDRAYFDTARWVDRQRRPRPYAWQGDADYFLRAVDQGIGRALWFIHGAHVDHVTAAVSAFAERRHADLWSGVGLAATFAGGAPALMTALRRNAGAHGGHLAQGAVFAAKARHHCGHVPEHTRAAVQALTGLEVRAAAELADDCAVPASESGVVPTYEIWRRRVRERVSAVSV	MNRTVMMALVIIFLDAMGIGIIMPVLPALLREFVGKANVAENYGVLLALYAMMQVIFAPLLGRWSDRIGRRPVLLLSLLGATLDYALMATASVVWVLYLGRLIAGITGATGAVAASTIADVTPEESRTHWFGMMGACFGGGMIAGPVIGGFAGQLSVQAPFMFAAAINGLAFLVSLFILHETHNANQVSDELKNETINETTSSIREMISPLSGLLVVFFIIQLIGQIPATLWVLFGEERFAWDGVMVGVSLAVFGLTHALFQGLAAGFIAKHLGERKAIAVGILADGCGLFLLAVITQSWMVWPVLLLLACGGITLPALQGIISVRVGQVAQGQLQGVLTSLTHLTAVIGPLVFAFLYSATRETWNGWVWIIGCGLYVVALIILRFFHPGRVIHPINKSDVQQRI	80.49	gnl|BL_ORD_ID|147|hsp_num:0	142			33	432	tetracycline
BGC0000112.1|Neocarzinostatin_42 # 53529 # 54029 # -1 # ID=1_42;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.657	BGC0000112.1|Neocarzinostatin_42 	53529	54029	-	Loose	1650	25.0238	Brucella suis mprF	26.32	3003772	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	ATGCGATTCCTCCCCGGCGTGAACGCCGGGGCCTCCTCGCAAGAATCAGGTGAGACCATGCTGAAGCACACGTACGAGGGGCAGGACTGTAGCCTGGCCCGTGCCCTTGAAGTCATCGGTGAACGCTGGACACTGCTCATCGTCCGTTCGGCGCTGCTCGGTGTCCGCCGCTTCGAAGGCTTCCTTGGCAGCATGGACATCGCCCGCAACGTTCTGGCGAACCGGCTGGTGCGACTGGTTGACGCAGGCCTCATGGAGCGAGTTCCCTACCAGTGGAAACCCCTTCGTCACGAGTACGTGCTGACTTCCGCCGGACATGACCTCACGCGGTCGGTCATAGCGCTCATCCAGTGGGGCGACCGGAACGTGCCCGCGCGCCTGGGGCCCCCGCGCAGGGCCGAGCACCGCGGGTGCGACGGATCCGTCTCCGTCGAGCTGCACTGTTCGCGCTGCGGTCACGAAGTCGGTGACGAGGAAGTGACGATGCGACGCCTGCGGTGA	MRFLPGVNAGASSQESGETMLKHTYEGQDCSLARALEVIGERWTLLIVRSALLGVRRFEGFLGSMDIARNVLANRLVRLVDAGLMERVPYQWKPLRHEYVLTSAGHDLTRSVIALIQWGDRNVPARLGPPRRAEHRGCDGSVSVELHCSRCGHEVGDEEVTMRRLR	MLWWDDISMSLIDDEIPSSQPQVSGRHFGWLKQYQHFLFPIAGIAIALLAIYVLENLLRHTSRTETLAALHNISWTTLALAVFFTALSYAAVALYDVVAVDTIAPNQIPRRIAAVAGAAGYAISNALGFSLLTGGALRYRIYAAEGISLADIGKIVGTSWFAIWFALIIMVGAALLIDPQDVPFLSAIDIRIDIVAGILILGGIGWLIYWLSHGERNVSIGSFSLRLPNSKGALTQIFAGVVDVGAAAATLYVLLPEGAVPSFAVFALVYVIAIVLGIASHAPGGLGAFEATIIAGLGLGGKPDAIAGLLAYRLIYTVLPLVVATAGILIWEVMRRRHMLDKQARFAKRLVEPLVPGLSASIIFLGGIILLISGATPDMRYRVKLLSDIVPEFLVEMSHLAASLVGVALLIVARGLSKRLERAWVAAMVLLLCGAVFSIAKGLDWEEASILCLFALSLWGFRDSFYRRPIAGPFELSWNWIATVGTTVLVSTWLGFFVYRHIEYSSDLWWDFAWNGNAPRFLRATVLVFAVVAAVGLHSIINRHGQRRRKVDHSIPDAVPALVARCPHTDAALAMLGDKQFLLAPDDSAFIMYAQSGGSLIALGEPIGDAEAGKELAWSFHSLADRLALRTVFYGVGPQSLPLFLDMGLIALKLGEVARVDLTDFSLEGPRRQPFRYADRKVDKDGLTFEIIPAADVPPLIPRLRAISDAWLDHKSGSEKGFSLGYFNDEYLKRFDIAVLKKDGEIVAFANIWRGADKYEITVDLMRYMPNVHKLLMDALFAKLLTFSKQEGYKWFNLGAAPLSGLSGSRLASRWNRFGSFIYRRGADLYHFDGLKAFKEKFDPVWTPHYMVCPGGLETPRALLDATTLINGSPLEFIRK	18.86	gnl|BL_ORD_ID|2057|hsp_num:0	2281			372	600	defensin
BGC0000112.1|Neocarzinostatin_43 # 54304 # 55470 # 1 # ID=1_43;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.704	BGC0000112.1|Neocarzinostatin_43 	54304	55470	+	Loose	400	27.7202	QnrS5	36.21	3002794	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic target protection	quinolone resistance protein (qnr)	TTGCGTGTGTCGTCCGGTGCCCGCACGGCTCTGGTGGCGGAGTGGGGCCGGTGCCGCTGGGTGTGGAACGAGTGCGTCGCCAAGCCCAGGGCCGTACACCAGCACAACAAGGCGACCGGCGAGAAGGCCACGTGCGGCCCGGCCCTGCTGGACAGGATGCTGACCAAGGCCCGCGCCCGTACGCCGTGGCTGCGGGAGGGCTCTTCGGTTGTGCAGCAGCAGGTCATCCGCGACTTCGGCCGCTCCCGCGCCAAGGCGCACCAGGACCTCAAAGACGGCCTGCCCCTGGCGCGCCGGGCCGGGATACCGAAGTGGAAGACCCGACGCGAGGCGCTGCCGAGTCTCAACTACACCCGGCGTGGGTTCCGGCTGAAGGACGGCCGGCTGCACCTGGCGGGCGGCGTCGTCCTGACGGTGGTGTGGTCGCGGGATCTGCCGGGTGAGCCGTCCTCGGTGCGCGTGTACCAGGACAGTCTCGGGCACTGGTACGGCTCGTTCGTCGTCCCCGCTCAGGTCGAGCCGCTGCCTGCGACCGGCCGCGTGCTCGGTGTCGACTGGGGCGTGAAAGAGACGGCGACCACCACGTCCGGCGCGCACGATCTGCCGCATGCCGGGCACAGCGGGACGGCCCGGGCGAAGCTGACCCGGTACGACCGGATGACAGCCCGCCGCAGACCACAGAAGGGGCGGCCCGGCTCGAAGGGCTACCGGGAGGCGAAGAGGCTGCGGGCGAAGGCCCACAAGAAGGTCGCCAGGCAGCACGCGGACACCGGCTGCAAGTGGGCCATGAAGGTAGTCCGCGACCACGACGCCATCGCCGTCGAGGACTTCCGCCCGAAGTTCCTGGCCAGAACCACGATGGCCCGCAAGGCCGCCGACGCCGCCATCGGCGCCACCAAGGCCGCTCTGATCGAGATGGGCCGCAAACACGGCCGGGACATCCGCCTGGTCCACCCCGCGCACACCACCATGGACTGCGCACAGTGCGGAGCGAGAACCAAGCACGCACTCCCCCTCTCCGAACGTACCTACACCTGCACCGCCTGCGGAACCGTCTGCCCACGGGACAAGAACTCCGCACGCGTCATGCTCGTCCGGGCTGGTCTCAACCCGGCTGGTGCCGATGGCAGAAGACCTCCTGGAGCGCTGCTCCAGGAGGCAGCCTGA	MRVSSGARTALVAEWGRCRWVWNECVAKPRAVHQHNKATGEKATCGPALLDRMLTKARARTPWLREGSSVVQQQVIRDFGRSRAKAHQDLKDGLPLARRAGIPKWKTRREALPSLNYTRRGFRLKDGRLHLAGGVVLTVVWSRDLPGEPSSVRVYQDSLGHWYGSFVVPAQVEPLPATGRVLGVDWGVKETATTTSGAHDLPHAGHSGTARAKLTRYDRMTARRRPQKGRPGSKGYREAKRLRAKAHKKVARQHADTGCKWAMKVVRDHDAIAVEDFRPKFLARTTMARKAADAAIGATKAALIEMGRKHGRDIRLVHPAHTTMDCAQCGARTKHALPLSERTYTCTACGTVCPRDKNSARVMLVRAGLNPAGADGRRPPGALLQEAA	METYRHTYRHHNFSHKDLSALTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFITGCTLSYANMERVCLERCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQEQLLEALGIVVFPD	177.98	gnl|BL_ORD_ID|356|hsp_num:0	393			297	471	ciprofloxacin; levofloxacin; moxifloxacin; gatifloxacin; nalidixic acid; norfloxacin; sparfloxacin
BGC0000112.1|Neocarzinostatin_45 # 57067 # 57690 # 1 # ID=1_45;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.665	BGC0000112.1|Neocarzinostatin_45 	57067	57690	+	Loose	375	42.3578	Escherichia coli AcrAB-TolC with AcrR mutation conferring resistance to ciprofloxacin, tetracycline, and ceftazidime	30.16	3003807	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGTGAGACAAGAACGAGCTGAACGTACCCGTGCGGCCGCAGTGCGTACTACGGCCGCAGAGATCGACCTCAAGGGCTATGACGGTACGTCACTTTCAGCGGTCAGCAAGATCGCAGGCATGTCCGTGGGGGCACTGACCTTTCACTTTCCCTCGAAGAACGACTTGGCAAACGCCGTCTGGCAAGCGGGGCAGTCCCTACTGAGGGAGGCAGTGGAGCGTGTGGCGGCCAACCGGACACCTCCGTTGCTGCGGGTGATCGAGCTCAGTCTGGTCATCGCGGACCTCATGGAGAAGGAGACCACCGTGCGTGCCGCCATCCGGCTGTCCCGGGAGTCGCATACCCCGTCCCACTGGTCGGACTGCTGGGTGCCGGAAGTACGGCGGCTGCTCAGCGAGGCCCACCGCGGGGGCCAGCTCAGCGAAGACACACCGGTCGAGGACCTCACCGTCCTGGTGCAGTACCTGGTCGACGGCACCGAGGCGTACCTCCGGGCCCGGCGCGACACGGAACAGGGGTACGGCAGCGCCGCGGCACAACTCGAGCGCCTGTGGGCGTTGGTCCTGACAGGGGTGCAGGACGCGGGAGCACTTGGTAGGAACCCGCCGCCGGCCCGGTCCTGA	MVRQERAERTRAAAVRTTAAEIDLKGYDGTSLSAVSKIAGMSVGALTFHFPSKNDLANAVWQAGQSLLREAVERVAANRTPPLLRVIELSLVIADLMEKETTVRAAIRLSRESHTPSHWSDCWVPEVRRLLSEAHRGGQLSEDTPVEDLTVLVQYLVDGTEAYLRARRDTEQGYGSAAAQLERLWALVLTGVQDAGALGRNPPPARS	MARKTKQEAQETRQHILDVALRLFSQQGVSSTSLGEIAKAAGVTRGAIYWHFKDKSDLFSEIWELSESNIGELELEYQAKFPGDPLSVLREILIHVLESTVTEERRRLLMEIIFHKCEFVGEMAVVQQAQRNLCLESYDRIEQTLKHCIEAKMLPADLMTRRAAIIMRGYISGLMENWLFAPQSFDLKKEARDYVAILLEMYLLCPTLRNPATNE	96.28	gnl|BL_ORD_ID|2090|hsp_num:0	2306			15	204	tigecycline; ciprofloxacin; tetracycline; ceftazidime; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000112.1|Neocarzinostatin_46 # 57735 # 58715 # -1 # ID=1_46;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=10bp;gc_cont=0.692	BGC0000112.1|Neocarzinostatin_46 	57735	58715	-	Loose	500	26.5646	sul1	44.44	3000410	protein homolog model	n/a	n/a	sulfonamide antibiotic	antibiotic target replacement	sulfonamide resistant sul	ATGAGCCCTCCACTGCGCGTGGTCATCACCGGAGCCACGGGGTTCATAGGTTCTGCCGCACTGCGTGAACTGGCCCGGTCGCGGAGATCCCGAGGCACCGGCGTCGGACCTCTTGTCATCCGTGCGCTCGGGCGCCGAGAGCCGGACACGTCGCTCATCGACGAGTGGGTGTACGCGGATCTGACCCAGCCCGAAACCCTGGCAGGGGCCTGCTCGGAGGCCGACGTGCTGTTGCATCTGGCCTCGTTCGTCGGTTCGGACCCGGACATGTGCGAGAGGGTCAACACGGTCGGCACGGCGGTGCTCATGGACGACGCAGTCCGTTGTGGAATCGAGCGAGTCGTTCACCTTTCGACGGCCGCCGTCTACGGGCCGGGTCCCCATCGCGGCACCACCGTCGGCGAGCTCGCGCCCGCGCCCGTCTCGGCCGTGAGCCGCTCACGGCTCGCCGGCGAGGCACACGCACTCGCCGCGGGGGCCGACGTGCTTCGCACCGGCCTGGTGGTAGGAGAGGGCGACCGCTGGGTGATCCCGGCCGTGGCCAAGCTTTTCGACGCGGTCCCCGGCCTGTGGGACGGAGGGCGGGCACGTGTCTCCATGATCGCGGTGGAGGACTTGGCCCGCCTCGTCGTCAGTCTGGTCGGCACGGGACGCCCCTCTCGCAACAGGGTGTTCCATGCGTGCCATCCGGCGCCCCTGAGCTGTGGCGAGTTACTGAGGGGCCTCGCCCGACTGGAGCTGCTGCCGTCGCTGCCGGAGGTGGGCGAGTTGTCCTGGCAGGAGTGCCTTCGGCAACTGCGCTCCGCCGATTGCGGTGTCAGTGAACGCCAGTTCGCACTCGTCGCCCGCGACAACTGGTTCGACAGCGAGGACATTTGGCGGGTGGCCGGCTGCTCACCAGGACACGGCCCTCTTCGCAGCATCGAGGAAGCCGCCCCCTGGTACCGGTCGCTCATGTCTGCCCGGACGGTGACGCCCTGA	MSPPLRVVITGATGFIGSAALRELARSRRSRGTGVGPLVIRALGRREPDTSLIDEWVYADLTQPETLAGACSEADVLLHLASFVGSDPDMCERVNTVGTAVLMDDAVRCGIERVVHLSTAAVYGPGPHRGTTVGELAPAPVSAVSRSRLAGEAHALAAGADVLRTGLVVGEGDRWVIPAVAKLFDAVPGLWDGGRARVSMIAVEDLARLVVSLVGTGRPSRNRVFHACHPAPLSCGELLRGLARLELLPSLPEVGELSWQECLRQLRSADCGVSERQFALVARDNWFDSEDIWRVAGCSPGHGPLRSIEEAAPWYRSLMSARTVTP	MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA	116.85	gnl|BL_ORD_ID|979|hsp_num:0	1070			645	741	sulfadiazine; sulfadimidine; sulfadoxine; sulfamethoxazole; sulfisoxazole; sulfacetamide; mafenide; sulfasalazine; sulfamethizole
BGC0000112.1|Neocarzinostatin_47 # 58712 # 59296 # -1 # ID=1_47;partial=00;start_type=TTG;rbs_motif=AGGA;rbs_spacer=8bp;gc_cont=0.658	BGC0000112.1|Neocarzinostatin_47 	58712	59296	-	Loose	390	45.8246	MexZ	27.27	3003709	protein overexpression model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGATCCTCCGTGCCGCTGCTGAGGTGTTCGACGAGAGCGGATACAGCGGGGCGAGCATCAGTAAAATCATGAACCGCGCCGGCGTGACCCAGGGGGGCATGTACTTCCACTTCAAGTCGAAGAAGAGGCTGGCCCTGGCAGTGATGAGCAGTCAGCAGACCTTCATCGACTTCCCCTCAGAAGGTGCCGGTCTGCAGCGAGTGATCGACCTCACCTTCCACCTCGCTCACGAGCTCCAGACCAACCCCCTGATCCGGGCCAGCATCCGGCTCGCCGTCGAGCAGGGAGAGTTCGGCGTCCGCGACGACACCGCCTACCAGGACTGGGTAGCCCTGGTGGAGACCTACCTGCTGGAGGCGCGCCAGCGGGGCGAACTGCTCCCGGAGGTGGACGAACACGACTTCGCCGTCGTTCTCGTCAGCGCGTTCACCGGTAGCCAGCTGTTCTCGAGCGTCGCCAGCGCCCGTGCGGATCTGCCCAGCAGGATCGTCCTGCTGTGGCGTTATCTGCTGCCTGGCCTCACGCCCCCTCGGACGAGGGCCTCCCTGCGGGTCGAGCCGGCGGACAGGACCCCGGCCACATGA	LILRAAAEVFDESGYSGASISKIMNRAGVTQGGMYFHFKSKKRLALAVMSSQQTFIDFPSEGAGLQRVIDLTFHLAHELQTNPLIRASIRLAVEQGEFGVRDDTAYQDWVALVETYLLEARQRGELLPEVDEHDFAVVLVSAFTGSQLFSSVASARADLPSRIVLLWRYLLPGLTPPRTRASLRVEPADRTPAT	MARKTKEESQKTRDGILDAAERVFLEKGVGTTAMADLADAAGVSRGAVYGHYKNKIEVCLAMCDRAFGQIEVPDENARVPALDILLRAGMGFLRQCCEPGSVQRVLEILYLKCERSDENEPLLRRRELLEKQGQRFGLRQIRRAVERGELPARLDVELASIYLQSLWDGICGTLAWTERLRDDPWNRAERMFRAGLDSLRSSPYLLLADA	92.38	gnl|BL_ORD_ID|4693|hsp_num:0	2223			45	489	erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; meropenem; chloramphenicol; arbekacin; norfloxacin; ofloxacin; gentamicin
BGC0000112.1|Neocarzinostatin_48 # 59458 # 60411 # 1 # ID=1_48;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.653	BGC0000112.1|Neocarzinostatin_48 	59458	60411	+	Loose	300	25.7942	tet(36)	31.37	3000197	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGCTTGGTACGGACGACCGTCCGGGCCCCGTTGAACCCGCACTGACCAGGACCGTTGCAAAGGAGTACGTACACAGGGCCGCGCTCGCGGAAGTGTTCTTGACGGGCTGGAACAGGACCGGCCCCGACTCATTTCTTGTCAGCGCCCAGTGGCCGCGCTCTCACAGCTTCTACAGCTCCGATCGCGGTGTCCACGACCCGCTGCTTCTGTGTGAAAGCCTACGTCAGTGTGGCCTGTTGCTGACCCACGCAGCGTTCAAGGTGCCCTTCGGCTACCAGCTCAGCTGGTCCAGCCTGCGGTACTCGGCCAACCCCGAGGCGATGCGTATCGGCAGCACCCCCGCCGACATCGAAATGCATGTACAGTGCACCGATGTTCGGTACCGGCGCTCCCTGCCCGTCGCGATGACCATGCGCATCGAGGTGGTGCTCGACTCGGCCCTTCTGGCCGTCGCCACCATCACGTTCGGCCAGCACGCCCCGGCTGTGTACCGCCGTCTCAGAGCCGGACGGTCGGACGCAGCCGGTCTGTGCGCGAACGCCCCGACCCCGGCTGCACCCATCCCCCCGTACGTGGCCGGACGCACCAGGCAGGAGGACGTAGTCCTGTCGCCCACGGAAGACCGACTGCGCTGGCGGCTGCGGGTCGACACCAACCACCCGGTGCTCTTCGACCACCCGGTCGACCATGTTCCGGGCATGCTGCTCCTGGAGTCCGTACGGCAAGCAGGCCATGCTGTACATCCGTCCGGCGGCGACGTGATGCCGACGTTGATGGACGTGTCGTTCAACCGCTACGTGGAGCTCGACGAACCCTGCTGGATAGAGGCGGAAGCGATGCCTTCCCCTGCCGGATCACGAAAGGCGACACGTGTCAACGGTCTTCAAGGCGGGAGACTCGCCTTCACGGCCGTCACTCAAATGACGGACATAACCGGCTCCCCTCCCTGCTGA	MLGTDDRPGPVEPALTRTVAKEYVHRAALAEVFLTGWNRTGPDSFLVSAQWPRSHSFYSSDRGVHDPLLLCESLRQCGLLLTHAAFKVPFGYQLSWSSLRYSANPEAMRIGSTPADIEMHVQCTDVRYRRSLPVAMTMRIEVVLDSALLAVATITFGQHAPAVYRRLRAGRSDAAGLCANAPTPAAPIPPYVAGRTRQEDVVLSPTEDRLRWRLRVDTNHPVLFDHPVDHVPGMLLLESVRQAGHAVHPSGGDVMPTLMDVSFNRYVELDEPCWIEAEAMPSPAGSRKATRVNGLQGGRLAFTAVTQMTDITGSPPC	MRTINIGILAHIDAGKTSITENLLFASGATIVRGSVDKGNTTTDSMDIEKRRGITVRASTTSIQWNDTKINIIDTPGHMDFLAEVERTFRMLDGAILVVSAKEGIQAQTRLLFNVLQQLEIPTILFVNKIDREGVNLNQLYLEIQNSLSKDIIFMQSVEGKELTSSCTIHYISEKNRETILEKDDLLLEKYLSDTQLSNLDYWNSMVRLVQAAKLHPIYHGSAMYGIGIEDLLNSITTFIETSLPQENALSAYVYKIEHNKKEQKRAYLKIIGGTLKSRKLYSLNGSDENLKIRGLKTFYSGDEIDVDEVFTNDIAIADHADNLMVGDYLGIMPNLFDKLNIPSPALKSSIHPAKVENRSKLISAMNVLSVEDPSLAFSINADNNELEVSLYGATQREVILTLLEERFSVDAYFEEVKTIYKERLKTKSEYTIHIEVPPNPYWASIGLIIEPLPIGAGLVMESEISLGYLNRSFQNAVFDGVKKACESGLYGWEVTDLKVTFSHGIYYSPVSTPADFRSLAPYVFRLALQQADVELLEPILDFKLQIPLAVNARAITDINKMQGEISTITSDGDWTTILGNIPLDTSKEYSAEVSSYTQGLGVFVTRFSGYRPTNKKVSRSVELNEKDKLMYMFEKESIK	49.53	gnl|BL_ORD_ID|1675|hsp_num:0	1708			1599	1752	tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0000112.1|Neocarzinostatin_49 # 60721 # 61563 # -1 # ID=1_49;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.674	BGC0000112.1|Neocarzinostatin_49 	60721	61563	-	Loose	800	26.9498	msrA	31.58	3000251	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic; streptogramin B antibiotic	antibiotic target protection	msr-type ABC-F protein	ATGGACCATTCCTCACACGCACCGCATCCGGCGGGAACCGCGGAGGGCATGAGCGCCGTCGCGAGCGCCGTCGATGTTGCGGGTGCCGTGTTCCTCGTCCTGTGGGCCGTCGCGATGTGGCTGGCCGTGTGCCTCCTCGCTTGGGCGAACAGAGGTCCGGTGAAGCCCTGGTTGTACCGGGGCTCGGTGGCGGTGATCGGTCTCGGCGTCATCGGCCAGGTCGGGCACTTCCAGGAACACGTCGCCCAGGCGGCCTACTGGATAGCGAATCCCGACGCACCCGCCTGGATGACGCCGTGGGGCGACGGCCTGGCCCGCGGCATGGGCGTCGTCGACCCGGACAATCCCACGCTGGGAATGGAGATCCTGCATCTGACGGGCAACTACGTCTTCCTGGCCGGACTGGTCGGCATCATGCTGATCACCAGCCGGGCGGTAACGGAACTGAAGTCTCGCCGGTGGGCGCGGATGGGGGTCTGGATGCAAGGCATTCATGGGCTCGAGCACGTTGCGCTGACGGTCTCCGTGGCCCTTGGCGCCGACCGTGCCATCGGACTTTCCACCTGGTTCGGTGCCATCCCCCCGGGTTCGGCCCTGACGACGTACCGCGTCTGGTGGCACTTCGTGGCCAACCTCGTCGGTACGGCGATCCTGACCGTCGCGGTCTTTCACCTGTGGCGTGAGCGGCGAAGCGTCAGGTTGTCCTACGCGGGCGGGGCATCCGATTCCGGCGAGCAGCGGGACGGTGTCGTCGGTTCCCCTCGGCGGGAGCCGACGACGAAGGCAGGACTCGCTGATTCGGACACGCAAGCGTCGACCGTCCTGACGGAACACGTCCCCTAA	MDHSSHAPHPAGTAEGMSAVASAVDVAGAVFLVLWAVAMWLAVCLLAWANRGPVKPWLYRGSVAVIGLGVIGQVGHFQEHVAQAAYWIANPDAPAWMTPWGDGLARGMGVVDPDNPTLGMEILHLTGNYVFLAGLVGIMLITSRAVTELKSRRWARMGVWMQGIHGLEHVALTVSVALGADRAIGLSTWFGAIPPGSALTTYRVWWHFVANLVGTAILTVAVFHLWRERRSVRLSYAGGASDSGEQRDGVVGSPRREPTTKAGLADSDTQASTVLTEHVP	MEQYTIKFNQINHKLTDLRSLNIDHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESGTVETNGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLRNVISNYSPILLLDEPTNHLDKIGKDYLNNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRVFKGNYTQYQNQYEQEQLEQQRKYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIAPDRLSASKEKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPIIAQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMAYYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALERSCNVLSGGERTKLSLAVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELTGQSIHDIT	57.38	gnl|BL_ORD_ID|1105|hsp_num:0	1200			1299	1461	erythromycin; quinupristin
